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ABSTRACT OF THE PROPOSAL 
The Effect of Non-Exercise Activity Thermogenesis on Subjects 
with Metabolic Syndrome 
by 
Samer Hammoudeh 
Doctor of Public Health Candidate in Preventive Care 
School of Public Health, Loma Linda University, 2012 
Dr. Serena Tonstad, Chair 
Metabolic syndrome is a cluster of metabolic abnormalities that increases the risk 
of cardiovascular disease and type 2 diabetes. Several criteria establish the diagnosis of 
metabolic syndrome, including high waist circumference, low HDL cholesterol, high 
triglycerides and glucose and above normal blood pressure. The prevalence of metabolic 
syndrome is on the rise following the rise in obesity across the globe. Qatar, a country in 
the Arabian Peninsula shares the burden of obesity with recent studies showing 
prevalences of'---61% among women and —39% among men. These studies found that 
metabolic syndrome is more common among women. Physical activity helps reduce 
visceral obesity, controls glucose levels, and improves blood pressure, triglyceride, and 
HDL cholesterol levels. One way of increasing physical activity is by promoting non-
exercise activity thermogenesis (NEAT). NEAT represents 10% of daily human energy 
expenditure and is expended during daily life activities like mowing the lawn or climbing 
stairs. A lifestyle intervention study was conducted with 200 Qatari subjects identified 
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with metabolic syndrome. The study was approved by the research committee at Hamad 
Medical Hospital in Doha, Qatar. The study aimed to reduce the number of components 
of metabolic syndrome in men and women with metabolic syndrome treated at the 
diabetes and endocrinology department by promoting increased NEAT. In a randomized 
clinical trial lasting one year the intervention group received general exercise and dietary 
guidelines in addition to information on how to increase their daily NEAT, while the 
control group received solely the general exercise and dietary guidelines. Subjects in the 
intervention group were asked to incorporate NEAT by modifying their work 
environment, and daily habits such as going shopping, standing instead of sitting, and 
walking instead of using the car. Text message reminders were sent to the intervention 
group at two, four, eight, and 10 months. Body weight, waist circumference as a measure 
of visceral obesity, blood pressure, glucose level and lipid profile were assessed at 
baseline, 6 months, and 1 year in both groups. Archival data obtained through this study 
were analyzed after gaining permission from the Loma Linda University Institutional 
Review Board. After 1 year 52 intervention and 55 control subjects completed the study. 
The results revealed no statistically significant differences in metabolic syndrome 
components between the two randomized groups. Additionally analysis of subgroups 
including those on anti-diabetic medication versus those not taking such medication 
revealed no differences between the intervention and control groups. The amount of 
recommended NEAT activity appears to have been too small to influence study 
outcomes. Future studies in similar populations may need to consider the high dropout 
rate, and use of incentives or culturally appropriate interventions to increase compliance 
and retention. 
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CHAPTER 1 
INTRODUCTION 
A. Statement of the Problem 
1. 	High Prevalence of Metabolic Syndrome 
Metabolic syndrome is a combination of several abnormalities that 
increase the risk of cardiovascular disease (CVD). Each abnormality is associated with 
cardiovascular disease cases (Bener et al., 2009), such as stroke, myocardial infarction, 
and heart failure (Musallam et al., 2008). These abnormalities may include, but are not 
limited to the following items, high blood pressure (hypertension), elevated levels of 
fasting glucose, insulin resistance (Bener et al., 2009), obesity, especially central obesity 
characterized by accumulation of fat in the abdomen, dyslipidemia characterized by low 
levels of HDL cholesterol, also known as "good cholesterol", and high levels of 
triglycerides (Meigs, 2003). The constellation of the above items increases the risk of 
developing diabetes, or impaired fasting glucose (Bener et al., 2009), and ultimately 
increases the risk of premature mortality (International Diabetes Federation (IDF), 2006). 
Meigs (2004) reports that obese patients with metabolic syndrome have a 10 fold 
increased risk of developing diabetes and a twofold increased risk for CVD, in 
comparison to individuals with normal weight and without metabolic syndrome. Meigs 
recommends aggressive lifestyle intervention in order to reduce the associated risk. 
Grundy et al. (2005) indicate that the primary goal in the clinical management of patients 
with this syndrome is focused around reducing risk of atherosclerosis by modifying risk 
factors like obesity, physical inactivity, and diet which may occur through appropriate 
lifestyle changes. 
Metabolic syndrome can be identified according to different criteria. For the 
National Cholesterol Education Program/Adult Treatment Panel III criteria, the person 
must have three or more of the following five abnormalities; (a) Fasting plasma glucose 
over or equal to 100 mg/dL (5.6 mmol/L), or drug treatment for elevated blood glucose; 
(b) HDL cholesterol less than 40 mg/dL (1.0 rnmol/L) for men, and 50 mg/dL 
(1.3 mmol/L) for women, or treatment for low HDL cholesterol; (c) Triglycerides over or 
equal to 150 mg/dL (1.7 mmol/L), or treatment for elevated triglycerides; (d) High blood 
pressure over or equal to 130/85 mmHg, or treatment for hypertension; (e) Obesity 
characterized by a waist circumference over or equal to 102 cm (40.15 inch) for men, and 
over or equal to 88 cm (34.64 inch) for women (Meil.2.,s, 2004). 
For the International Diabetes Federation, central obesity is the primary criteria 
with different cutoff scores for different ethnicities, with elevated waist circumference of 
over or equal to 94 cm for men, and 80 cm for women. Additionally, the patient must 
have two or more abnormalities out of four of the following: (a) Fasting plasma glucose 
over or equal to 100 mg/dL (5.6 mmol/L), or diagnosed type 2 diabetes; (b) High blood 
pressure over or equal to 130/85 mmHg, or treatment for hypertension; (c) Triglycerides 
over or equal to 150 mg/dL (1.7 mmol/L), or treatment for elevated triglycerides; 
(d) HDL cholesterol less than 40 mg/dL (1.0 mmol/L) for men, and 50mg/dL 
(1.3 mmol/L) for women, or treatment for low HDL cholesterol (IDF, 2006). 
In order to have a single definition, several organizations, including the above 
two, agreed on a harmonized definition in 2009. For the harmonized definition of 
metabolic syndrome, the person must have three or more of the following five 
abnormalities; (a) Elevated waist circumference which is population and country specific; 
(b) Elevated triglycerides over or equal to 150 mg/dL (1.7 mmol/L), or drug treatment for 
elevated triglycerides; (c) Reduced HDL cholesterol less than 40 mg/dL for males and 
less than 50 mg/dL for females, or drug treatment for reduced HDL cholesterol; 
(d) Elevated blood pressure over or equal to 130 mm Hg for systolic and/or over or equal 
to 85 mm Hg for diastolic, or drug treatment for hypertension; (e) Elevated fasting 
glucose above or equal to 100 mg/dL, or drug treatment for elevated glucose (Alberti 
et al., 2009). 
Worldwide, approximately 25% of the population suffers the burden of symptoms 
related to metabolic syndrome. Novak and Levine (2007), report that approximately one 
billion people worldwide are overweight or obese. After conducting a thorough literature 
review on metabolic syndrome in the Middle East, no comprehensive peer reviewed 
literature studies were found to provide accurate numbers of the prevalence in the area in 
general. Most studies focus on specific countries, such as Iran and Emirates. Both of 
these studies showed increased prevalence of metabolic syndrome among their 
populations. The burden is shared among the Qatari population, which suffer from high 
prevalence rates of obesity and type 2 diabetes. The metabolic syndrome prevalence rates 
in this population are about 26.4% according to the Adult Treatment Panel III (ATP) 
criteria, and 34% according to the International Diabetes Federation (IDF) criteria 
(Musallam et al., 2008). In regard to gender, females had higher prevalence rates. 
According to the ATP criteria the prevalences are 56.3% for females, and 43.3% for 
males with higher rates using IDF criteria (Bener et al., 2009). 
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2.• Metabolic Syndrome Risk Factors 
Some of the common risk factors include age, menopause, race, sex 
hormone disturbances, hyperandrogenism in pre and post menopausal women, high 
caloric intake, physical inactivity, family history, obstructive sleep apnea syndrome, and 
psychosocial and personality factors (Fan, 2007). The risk for metabolic syndrome 
increases with age; reports show that metabolic syndrome affects about 10% of those in 
their twenties in comparison to 40% of those that are in their sixties, while signs and 
symptoms can appear as early as childhood. For type 2 diabetes, risk is increased in 
people with a family history of type 2 diabetes, or with gestational diabetes during 
pregnancy. In regard to race, some ethnicities seem to have higher risk of developing this 
syndrome, such as Hispanics or Middle Easterners. For obesity, a body mass index (BMI) 
above 25 increases the risk of developing the metabolic syndrome. Abdominal obesity 
increases the risk; due to the effects of visceral fat accumulation and its several clinical 
implications which are discussed in more detail later (Mayo Clinic, 2009). 
Risk factors associated with metabolic syndrome in the Qatari population include 
age, ethnicity, obesity and family history of diabetes (Musallam et al., 2008). Musallam 
et al.'s study showed that abdominal obesity is the most common metabolic syndrome 
abnormality in the Qatari population. The authors attribute this to the general economic 
growth witnessed in that geographic area, for example increased levels of urbanization 
and lifestyle leading to increases in diabetes mellitus. Additionally, the hot weather 
environment seems to be a factor that limits physical activity. In regard to age, the study 
showed a nine fold increase in age specific prevalence of metabolic syndrome for the age 
group 20-30, who had a prevalence rate of 7.9%, and to above 60 years of age, a group 
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that had a prevalence rate of 70.3%. As for gender, women had higher prevalence rates 
than men, as 61.4% in comparison to 38.6% in men. The authors attribute this partially to 
cultural factors that restrict women engagement in outdoor activities. More individuals 
with family history of diabetes had metabolic syndrome in comparison to those not 
having a family history of diabetes in this population. 
3. Metabolic Syndrome Etiology 
Factors that play an important role in the development of this condition 
include genetics, sedentary lifestyle, cigarette smoking, progressive weight gain, and a 
Western diet high in carbohydrates, saturated fat, and low in fiber (Pitsavos et al., 2007; 
Schiltz et al., 2009). As for diet, an atherogenic one, which is rich in saturated fat and 
cholesterol, may increase the risk of developing CVD in individuals with metabolic 
syndrome, although it is not listed as a risk factor for the syndrome (Grundy et al., 2005). 
It is clear that excess consumption of energy, regardless of the macronutrient 
composition, is associated with visceral accumulation of excess fat (Levine, 2007). 
Meigs (2002) reports that certain genes may contribute to metabolic syndrome, as 
family studies show that specific metabolic risk factors may be transmitted from the 
parents to the offspring. These studies also show that certain gene abnormalities are 
associated with the fasting insulin levels, lipids and obesity of the metabolic syndrome. 
Kushner and Bessesen (2007) indicate that physical inactivity contributes to the 
risk of developing obesity related diseases, like metabolic syndrome. They give an 
example of the Harvard alumni study which reports that individuals participating in 
regular moderate intensity exercise activity have lower body weight in comparison to 
those reporting less physical activity. They highlight the importance of establishing 
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public health programs and interventions that address these issues and in turn help curb 
the obesity epidemic. The role of lifestyle is emphasized in the current study. 
Novak and Levine (2007) show that sedentary behaviors increase as physical 
activity decreases which leads to increased obesity and decreased health at the population 
level. They report that weight gain comes as a result of lower energy expenditure when 
compared to caloric intake. "Indeed increasing physical activity levels may be the 
missing link needed to reverse the current obesity trends" (p. 923). 
In most studies, physical activity is associated with a decreased risk of metabolic 
syndrome. Structured physical activity may help prevent metabolic syndrome (Ford et al., 
2005). Laaksonen et al. (2002) conducted a study on 612 individuals without metabolic 
syndrome to assess the role of physical activity in predicting metabolic syndrome 
development. Their results show that individuals practicing 3 or more hours of structured 
physical activity per week have decreased risk of developing metabolic syndrome by 
50%. Their results also showed that among high risk individuals, moderate to vigorous 
exercise was effective in reducing their risk of developing metabolic syndrome. 
In another study by Ford et al. (2005), individuals not participating in any 
moderate or vigorous exercise during their leisure time showed twice the risk of 
developing metabolic syndrome, outlining the fact that "excess weight and lack of 
physical activity are two important determinants of the metabolic syndrome" p. 608). 
"Increasing physical activity at the population level not only has potential to help 
tackle the obesity problem, but would also address many of the other key health 
problems" (Fox & Hillsdon, 2007, p. 116). The authors recommend that promoting 
physical activity is needed now more than ever before. For example, fewer current jobs 
require physical activity; labor saving equipment is being used in the home, work and 
even in retail establishments, changes in shopping patterns with the emergence of the 
internet, and increased self sufficiency in the home. Collectively these reasons have led to 
a reduction in energy expenditure, which in turn played a role in increasing related health 
problems. In regard to sedentariness, authors indicate that sitting and obesity are related 
in a dose response manner, as obesity risk increases with the increase in time spent sitting 
during leisure time. Additionally, this risk increases with the increase in time spent in the 
car while travelling. They conclude by recommending that reduction in this sedentary 
time should be a target for interventions and health policy (Fox & Hillsdon, 2007). 
One way to increase physical activity both on an individual and population level 
is through increasing non-exercise activity thermogenesis (NEAT), which is the energy 
used when conducting different life activities. James Levine (2007) describes it as 
"NEAT includes all those activities that render us vibrant, unique, and independent 
beings such as dancing, going to work or school, shoveling snow, playing the guitar, 
swimming, or walking in the modern mall" (p. 275). This includes movement of muscle 
groups that is not performed for the purpose of exercise, but for the purpose of fulfilling 
the requirements of daily life. 
Levine and Miller (2007) indicate that during the last 20 years the work 
environment shifted mainly to be a computer based one which contributed to a major 
reduction in energy expenditure and physical activity levels, whether at the individual or 
population level. They conducted a study assessing the effectiveness of NEAT in 
increasing energy expenditure during work time. They recruited 15 individuals and asked 
them to work on a vertical station composed of a treadmill with a computer on top of it, 
instead of the typical work station or desk. Their results showed a significant increase in 
energy expenditure during walking. Additionally, it showed a linear relationship between 
walking speed and energy expenditure in these individuals. Lanningham, Nysse, and 
Levine (2003) studied the difference in energy expenditure between using the elevator, 
dishwasher, and driving in compare to walking, taking the stairs, and washing dishes 
manually. The results showed that using the former three options increases ones energy 
expenditure by 120 calories per day. They conclude that this adds up to 12 pounds of fat 
per year. 
Levine and Kotz (2005) indicate that obesity is associated with a predisposition to 
be seated for a longer period of time in comparison to more lean individuals. The authors 
conclude that if obese individuals used this time to stand or ambulate they would enhance 
their energy expenditure by 350 kcal/day. Novak and Levine (2007) report that NEAT 
has an important influence on energy expenditure, that even small changes in NEAT 
overtime may have an influence on body weight. Wilson indicates that "NEAT may 
explain the majority of the difference between individuals in terms of their energy 
expended in a given day. In fact, it ranges from 15-50% of total calories expended in a 
given day depending on whether an individual is sedentary or active" (Wilson, 2004, 
p.2). 
According to Kate Trainor (2009) "the beauty of NEAT is that you can start 
anytime, anywhere. No need to wait for a gym membership to kick in or a new year to 
turn over, it's easy to incorporate" (p. 2). For an ideal NEAT office environment, Trainor 
recommends several NEAT enhancing activities such as replacing the chair with a 
treadmill or an exercise ball, or standing when on the phone while using a mini-sized 
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stepper. Also, Wilson suggests several items on how to enhance ones daily NEAT at 
work, for an example, to ignore the elevator and use the stairs, or to ambulate when 
reading instead of sitting (Wilson, 2004). 
Levine (2007) recommends two approaches to make people more active during 
their day. The first is an 'individualized approach' where NEAT enhancing activities are 
personalized according to ones daily life activities. The second is 'environmental re-
engineering' and involves changing the surrounding environment, whether at the house or 
at work. While other factors play a role in overall energy expenditure balance, the current 
study will be an attempt to increase NEAT specifically through certain lifestyle 
modifications associated with an individual's environment, or daily habits, by using 
NEAT enhancing activities. 
Novak and Levine (2007) suggest that NEAT may have an important contribution 
to overall energy expenditure, as small changes in physical activity overtime may have 
influence on body weight. For many, maintaining a healthy diet and regular exercise may 
be difficult goals to achieve which is why the authors recommend NEAT as an easy and 
accessible way to increase energy expenditure. 
B. Purpose of the Study 
The goal of this study was to determine whether NEAT can be used to reduce the 
burden associated with metabolic syndrome in Qatari patients. This was planned to be 
achieved by increasing the amount of energy used or calories burned throughout the day 
utilizing NEAT. The specific objectives of this study were: (a) to examine the effect of 
NEAT on the number of components of metabolic syndrome, and (b) to examine the 
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effect of NEAT on the number of subjects meeting the IDF definition of metabolic 
syndrome. 
C. Research Questions 
• Among men and women with metabolic syndrome, does advice to increase NEAT 
reduce the number of components of metabolic syndrome after I year? 
o Among men and women with metabolic syndrome, does advice to 
increase NEAT improve their waist circumference after 1 year? 
o Among men and women with metabolic syndrome, does advice to 
increase NEAT improve their glucose level after 1 year? 
o Among men and women with metabolic syndrome, does advice to 
increase NEAT improve their HDL levels after 1 year? 
o Among men and women with metabolic syndrome, does advice to 
increase NEAT improve their triglycerides levels after I year? 
o Among men and women with metabolic syndrome, does advice to 
increase NEAT improve their blood pressure after I year? 
o Among men and women with metabolic syndrome, does advice to 
increase NEAT improve their weight after I year? 
• Among men and women with metabolic syndrome, does advice to increase NEAT 
reduce the proportion of subjects meeting the IDF definition of metabolic 
syndrome? 
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D. Theoretical Justification 
1. 	Components of Human Energy Balance 
Human energy expenditure is divided into three major components: first, 
resting metabolic rate (RMR), which is the energy used at rest, and accounts for 
approximately 60% of energy expenditure in humans (Wilson, 2004). This is the energy 
needed for body functions like respiration, ion transport, blood flow, and maintaining 
cellular integrity. For men, the RMR is approximately equivalent to 1800 kcal, for a 
70 kg adult. For women, the associated RMR for a 50 kg adult is 1300 kcal. For 
sedentary individuals RMR may account for 50-70% of daily energy expenditure (Harvey 
& Ferrier, 2008). A study by Huang et al. (2004) showed higher RMR among severely 
obese individuals with type 2 diabetes in comparison to those without diabetes. Another 
study compared the RMR in obese, moderately obese and control individuals, and found 
that obese individuals have significantly higher RMR in comparison to those with normal 
weight (Ravussin et al., 1982). Thus, RMR is not a factor that is amenable to intervention 
in people with metabolic syndrome. 
The second component is the thermic effect of food. This is energy used during 
eating, digesting, and processing food (Wilson, 2004). During these processes heat 
production by the body increases as much as 30% above the normal resting level (Harvey 
& Ferrier, 2008). This accounts for approximately 10-15% of overall energy expenditure 
(Wilson, 2004). 
The third component is activity thermogenesis which may be divided into 
exercise and NEAT. This accounts for the remaining human energy expenditure (Wilson, 
2004). This component of human energy expenditure usually accounts for the majority of 
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variation in overall energy expenditure between different individuals and is most 
amenable to intervention of the components of energy expenditure. For an example, a 
sedentary individual may require 30-50% above resting caloric need, while a highly 
active individual may need up to 100% or more calories above resting caloric need 
(Harvey & Ferrier, 2008). While studies generally focus on increasing exercise, 
increasing NEAT may be an effective way of increasing energy expenditure. 
2. Non-exercise Activity Thermogenesis 
NEAT is the energy expended while people conduct life activities other 
than exercise, such as fidgeting and maintaining posture (NICHD, 2008). Levine defines 
NEAT "as those activities that render us vibrant, unique and independent beings, such as 
dancing, going to work or school, shoveling snow, playing the guitar, swimming, or 
walking in the modern mall" (Levine, 2007, p. 275). Levine et al. identify four 
environmental factors that have an influence on NEAT. First, the concrete urban 
environment and mechanization, as comparing the energy cost of mechanization to 
manual work shows that approximately 111 kcal per day is lost to mechanization. 
Second, gender, as women may have more duties than men in some societies. Third, 
education, as reports show that educated individuals report more leisure time in 
comparison to those with less education. Fourth, seasonal variations in physical activity 
(Levine et al., 2006) as reports from agricultural societies show that NEAT doubles in the 
summer as compared to the winter time (Wilson, 2004). 
Levine et al. (2006) show that NEAT plays an important role in overall energy 
balance because it may vary as much as 2000 kcal/day between individuals. Moreover, 
they indicate that highly active people may expend as much as three times more than 
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inactive people. In 2006, a study conducted at the Mayo Clinic, one of the prominent 
research institutes on the topic, found that the mean energy expenditure while seated was 
approximately 70 kcal/h, in contrast to walking and working which was about 190 kcal/h, 
with the mean increase of energy expenditure at approximately 120 kcal/h. The study 
concluded that replacing time sitting at the desk by time walking and working, 
individuals would lose 20-30 kg per year, if other components of energy expenditure 
remained the same (Levine & Miller, 2007). 
In another study by Levine, the author indicates that when a person walks at 
1 mile per hour, instead of sitting, the energy expenditure of a 70 kg person is 
approximately 100 kcal/h (Levine, 2007). Levine and Kotz (2005),in a third study, 
indicate that obesity is associated with a predisposition to be seated for a longer period of 
time in comparison to more lean individuals (about 160 min/day), and if these individuals 
used this time to stand or ambulate they would spend up to 350 kcal/day (Levine & Kotz, 
2005). 
3. Non-exercise Activity Thermogenesis Mechanisms in Reducing 
Components of Metabolic Syndrome 
As identified by the harmonized definition of metabolic syndrome, the 
main components are elevated waist circumference, elevated triglycerides or drug 
treatment for elevated triglycerides, reduced HDL cholesterol or drug treatment for 
reduced HDL cholesterol, elevated blood pressure or drug treatment for hypertension, 
and elevated fasting glucose or drug treatment for elevated glucose. 
a. Elevated Waist Circumference. Fan (2007) indicates that adipose tissue 
is a metabolic and endocrine organ that is highly active, as it is responsible for releasing 
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fatty acids, cytokines, and inflammatory mediators. This may contribute to the 
cardiovascular and metabolic risk associated with metabolic syndrome. Ford et al. (2005) 
indicate that physical activity and metabolic syndrome are inversely associated, as 
sedentary behaviors contribute to different components of the syndrome. In the 
previously mentioned study by Levine and Miller who compared the energy expenditure 
of persons sitting in front of a computer screen to those using a 'walk and work' desk 
station, the results show that there was a mean increase in energy expenditure for using 
the station over sitting of 119 kcal/h. The authors conclude that if obese individuals 
replace their sitting time with walking, an annual weight loss of 20-30 kg may occur 
(Levine & Miller, 2007). 
In a study by Levine et al. (1999), NEAT was found to be a significant predictor 
of resistance to fat gain with overfeeding (r = 0.77, p < 0.001), as participants with higher 
levels of NEAT had lower fat available for storage, in compare to those with lower levels 
of NEAT and higher predisposition for obesity. The authors conclude that enhancing 
NEAT through behavior modification may be useful in preventing obesity. 
Levine and Yeager (2009) show that choosing a more active option during daily 
activities increases energy expenditure. For an example a person would spend 
approximately 15 calories when parking the car next to work and using the elevator, 
while the amount of calories burnt increases to approximately 80-120 if parking was 
further away and the stairs were used instead. The table below provides further examples 
of more active options. 
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Typical day at the 
office 
Calories burned Picking up the pace Calories burned 
Park by building, 
take elevator 
15 Park 5 blocks from 
office, take stairs 
80-120 
Make phone calls 
for an hour at desk 
15 Take calls standing 
up and pacing 
100-130 
Seated 45 minute 
lunch 
25 Walk 30 minutes to 
lunch, sit and eat 15 
minutes 
100-130 
Seated 1 hour lunch 15 1 hour walking 
meeting 
150-200 
Take elevator to 
ground floor, walk 
to car, drive home 
15 Take stairs out of 
the building, walk 
back to car 
80-100 
Total 85 Total 510-680 
b. Lipids. ManTugat et al. conducted a study on 537. individuals to assess 
the role of physical activity in modifying the different components of their lipid profile. 
Their results show that individuals participating in leisure physical activity greater than 
7 kcal/minute had a significant increase in their HDL cholesterol and reduction in their 
atherogenic index, independent from other confounding variables. Additionally, it 
showed that participating in physical activity with intensity higher than 9 kcal/minute was 
associated with decrease in total cholesterol and non HDL cholesterol (Marrugat et al., 
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1996). Gutierrez recommends physical activity and exercise as an adjunctive intervention 
because of its positive impact on abnormal lipids. Exercise improves HDL cholesterol 
levels through altering composition and maturation of the particles, as it increases the size 
of HDL particles and the maturation of the nascent HDL particle. Additionally it 
improves total cholesterol levels (Gutierrez, 2007). The improvement in HDL cholesterol 
levels is due to increase in lipoprotein lipase activity which is responsible for breaking 
down triglycerides (Kravitz & Hayward, 2011). 
Kraus and Slentz (2009) indicate that moderate intensity exercise is significantly 
more effective in improving triglyceride levels and insulin sensitivity than vigorous 
intensity exercise. Additionally, it significantly improved a composite score for metabolic 
syndrome. They suggest that regular walking is an effective method in reducing health 
risk including the risk of developing cardiovascular disease, which comes through 
favorable changes in fasting lipids and atherogenic dyslipidemia. 
c. Glucose. Reaven (2002) indicates that resistance to insulin mediated 
glucose disposal increases a person's risk of developing abnormalities associated with the 
metabolic syndrome. He shows that physical activity enhances insulin sensitivity which 
in turn reduces the risk of CVD. Grundy et al. (2005) indicates that insulin resistance is 
an essential cause of metabolic syndrome, as it contributes to hyperglycemia of type 2 
diabetes. Additionally, insulin resistant individuals usually have abnormal fat distribution 
which is characterized by upper body fat. The authors show that the high release of fatty 
acids contributes to the accumulation of lipids in other sites than adipose tissue such as 
liver and muscles which contributes to worsening insulin resistance in the muscles for an 
example. Furthermore, they show that in patients with metabolic syndrome, physical 
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activity may delay or prevent the development .of type 2 diabetes. They further conclude 
by indicating that glycemic control reduces both associated microvascular and 
macrovascular complications. 
Healy etal.. (2007) showed a significant association between the effect of light 
intensity physical activity and glucose levels among 173 participants. They concluded the 
substitution of light intensity activity for other sedentary time may be a successful 
prevention method that contributes to the reduction of both type 2 diabetes and CVD risk. 
In another study, Gordon et al. (2008) looked into the effects of yoga and exercise 
combined in comparison to a control group on lipids among 77 patients with type 2 
diabetes. This 6-month study showed significant reductions in fasting blood glucose and 
both total cholesterol and VLDL cholesterol levels. They concluded that yoga and 
exercise can be used as a preventive therapeutic measure for type 2 diabetes patients. 
Another study looked into the effect of aerobic exercise and impaired fasting 
glucose and type 2 diabetes. This was a prospective study, with an average follow up of 
6 years, which was conducted on 8633 individuals without diabetes. These were divided 
into three groups with low, moderate, and high fitness. The results showed that those in 
the low fitness level have a 3.7 fold greater risk of developing diabetes in comparison to 
those in the high fitness group. Additionally it showed a dose response gradient between 
the assigned fitness level and incidence of both impaired fasting glucose and diabetes. 
They concluded that a sedentary lifestyle is a contributor to the progression from normal 
fasting glucose to impaired fasting glucose and diabetes (Wei et al., 1999). 
d. High Blood Pressure. Reaven (2002) indicates that patients with 
hypertension are at higher risk of developing cardiovascular disease. Grundy et al. (2005) 
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show that lifestyle changes are crucial in hypertensive individuals with metabolic 
syndrome. They recommend physical activity as a tool to help control elevations in blood 
pressure. The Mayo Clinic on their website indicates that not getting enough exercise and 
having high blood pressure are closely related. For some, participating in regular physical 
activity lowers the need for anti hypertensive medication. They show that physical 
activity helps in strengthening the heart so that it requires less effort to pump blood 
through the arteries which helps lower blood pressure (Mayo Clinic, 2011). 
Arroll and Beaglehole (1992) show that physical activity reduces blood pressure 
in both hypertensive and non hypertensive individuals, with an average reduction of 6-7 
mmHg for both systolic and diastolic blood pressure, indicating that this is comparable to 
drug treatment for hypertension, and concluding that this effect is independent from other 
factors. The results of another study by Padilla et al. (2005) shows that physical activity 
is effective in reducing systolic blood pressure in hypertensive and prehypertensive 
individuals, suggesting that physical activity may be used to treat both hypertension and 
prehypertension. Another study by Kerrie et al. (2001) showed that walking for 30 
minutes over a 24 week period reduced systolic blood pressure in women with borderline 
to stage 1 hypertension. 
In this study, NEAT is used to increase the energy expenditure among participants 
in the intervention group, which reflects positively on the waist circumference, glucose 
level, blood pressure, and lipid profile, which in turn reflects on the number of metabolic 
syndrome components along with the number of patients. The theoretical framework of 
this study is outlined in Figure 1.1. 
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Improve health and decrease 








Figure 1.1 NEAT contributes to energy expenditure by causing more calories to be 
burned, which may reduce the number of metabolic syndrome components and the 
number of subjects with metabolic syndrome. 
E. Significance to Preventive Care 
The results of this study may provide preventive care specialists with another tool 
that may aid in improving the health of subjects with metabolic syndrome, through 
reduction in the number of metabolic syndrome components. A tool that may be used as 
part of overall lifestyle recommendations given by preventive care specialists to improve 
the life quality of subjects with metabolic syndrome. It may also have an impact for 
recommendations given to individuals who feel they cannot exercise or are not motivated 
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to do so. In the long run, increasing the amount of energy used throughout the day 
utilizing NEAT, may be further reflected in a lowering of certain metabolic syndrome 
markers, and or decreasing risk of developing metabolic syndrome, and decreased risk for 





The increasing prevalence of metabolic syndrome in Qatar is just one indication 
among many that this population is suffering as a result of major lifestyle changes that 
have occurred in the past four decades. This literature review should serve to (a) identify 
factors behind the rise of metabolic syndrome prevalence, (b) evaluate current efforts to 
curb the prevalence, and (c) explore possibilities of improving the overall quality of life 
among metabolic syndrome patients. 
This literature review is divided into two main sections. The first covers an 
overview of metabolic syndrome along with its different definitions, the prevalence 
globally and in Qatar, risk factors, and implications. The second part discusses NEAT; 
how it has been used previously, how it has been used in the current study, how it 
influences energy expenditure, and recent studies on the topic. 
After conducting my research over the past few months, it was found that Dr. 
James Levine at The Mayo Clinic has provided the foundation of work done on NEAT. 
Several of his studies on the topic will be covered here. 
B. Metabolic Syndrome Overview 
Metabolic syndrome is a health condition which involves a combination of 
abnormalities in one person, this may include but not limited to the following items; high 
blood pressure (hypertension), elevated levels of fasting, glucose, insulin resistance 
(Bener et al., 2009), obesity especially central obesity characterized by accumulation of 
fat in the abdomen, dyslipedimia characterized by low levels of HDL cholesterol, also 
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known as "good cholesterol", and high levels of triglycerides (Meigs, 2003). The 
constellation of the above items increases the risk of developing diabetes, or 
cardiovascular disease (CVD) (Bener et al., 2009) and ultimately increasing the risk of 
mortality (International Diabetes Federation (IDF), 2006). For an example, Grundy et al. 
(2005) showed that adipose tissue among obese individuals is usually insulin resistant 
which increases fatty acid levels, thus increasing insulin resistance in muscle tissue. 
Furthermore, this adipose tissue produces abnormal adipokines which also alters insulin 
resistance and increases risk for CVD. The health risk associated with metabolic 
syndrome is discussed in more detail under the clinical implications section. 
Factors that play an important role in the development of this disease include 
genetics, sedentary lifestyle, cigarette smoking, progressive weight gain, and a Western 
diet (Pitsavos et al., 2007; Schiltz et al., 2009). Lifestyle plays a major role in the etiology 
of metabolic syndrome either through low physical activity or excess caloric intake or 
both. The most common risk factor seems to be abdominal obesity which majorly 
justifies lifestyle modification. The American Heart Association states that "in the long 
run, the greatest benefit for those with metabolic syndrome will be derived from effective 
lifestyle intervention" (Minich & Bland, 2008). 
C. Different Criteria for Metabolic Syndrome 
Several criteria establish the diagnosis of metabolic syndrome, these vary by 
geographical region or by the organization that issues the definition. Currently, five 
definitions of metabolic syndrome exist, these were established by the World Health 
Organization (WHO) in 1999. the American Association of Clinical Endocrinologists 
(AACE) in 2003, the European Group for the Study of Insulin Resistance (EGIR) in 
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1999, the International Diabetes Federation (IDF) in 2004, and the National Cholesterol 
Education Program/Adult Treatment Panel III (NCEP/ ATP III) in 2001 (Meigs, 2004). 
The most popular and widely used are the definitions by the National Cholesterol 
Education Program and the International Diabetes Federation and more recently the 
harmonized definition; these are discussed in detail below. 
1. Harmonized Definition of Metabolic Syndrome 
The patient must have three or more of the following five abnormalities; 
(a) Elevated waist circumference which is population and country specific; (b) Elevated 
triglycerides over or equal to 150 mg/dL (1.7 mmol/L), or drug treatment for elevated 
triglycerides; (c) Reduced HDL cholesterol less than 40 mg/dL for males and less than 
50 mg/dL for females, or drug treatment for reduced HDL cholesterol; (d) Elevated blood 
pressure over or equal to 130 mm Hg for systolic and/or over or equal to 85 mm Hg for 
diastolic, or drug treatment for hypertension; (e) Elevated fasting glucose above or equal 
to 100 mg/dL, or drug treatment for elevated glucose (Alberti et al., 2009). 
2. International Diabetes Federation 
Central obesity is the primary criteria with different cutoff scores for 
different ethnicities, with elevated waist circumference of over or equal to 94 cm for men, 
and 80 cm for women. Additionally, the patient must have two or more abnormalities out 
of four of the following,: (a) Triglycerides over or equal to150 mg/dL (1.7 mmol/L), or 
treatment for elevated triglycerides; (b) HDL cholesterol less than 40 mg/dL 
(1.0 mmol/L) for men, and 50 mg/dL (1.3 mmol/L) for women, or treatment for low HDL 
cholesterol; (c) High blood pressure over or equal to 130/85 mmHg, or treatment for 
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hypertension; (d) Fasting plasma glucose over or equal to 100 mg/dL (5.6 mmol/L), or 
diagnosed type 2 diabetes (IDF, 2006). 
3. National Cholesterol Education Program/Adult Treatment Panel III 
The patient must have three or more of the following five abnormalities; 
(a) Obesity characterized by waist circumference over or equal to 102 cm (40.15 inch) for 
men, and over or equal to 88 cm (34.64 inch) for women; (b) Triglycerides over or equal 
to150 mg/dL (1.7 mmol/L), or treatment for elevated triglycerides; (c) HDL cholesterol 
less than 40 mg/dL (1,0 mmol/L) for men, and 50 mg/dL(1.3 mmol/L) for women, or 
treatment for low HDL; (d) High blood pressure over or equal to 130/85 mmHg, or 
treatment for hypertension; (e) Fasting plasma glucose over or equal to 100 mg/dL (5.6 
mmol/L), or drug treatment for elevated blood glucose (Meigs, 2004). 
D. Metabolic Syndrome Prevalence Worldwide 
"The metabolic syndrome is very common and will become even more common 
as populations age and become more obese" states Meigs in a report in 2002 (p. 283). 
Estimates by the International Diabetes Federation in 2005 in regard to the worldwide 
prevalence of metabolic syndrome indicate that approximately 25% of the population 
suffers the burden of symptoms related to metabolic syndrome (IDF, 2006). Other studies 
show that up to 30% of middle aged individuals in developed nations have several 
features of this disease, with prevalence increasing up to 60 % of individuals in their 
70's, with a minimal 30% of all adults living without any features (Haslam, 2005). 
In the United States, according to the National Center for Health Statistics in a 
report published in 2009, approximately 34% of adults meet the criteria set by the 
National Cholesterol Education Program/Adult Treatment Panel III (Ervin, 2009). For the 
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age category under 40 years, 20% of males and 16% of females meet the criteria. For the 
age category 40-59 years, 41% of males and 37% of females meet the criteria. And 
finally, for the age category 60 years and over, 52% of males and 54% of females meet 
the criteria. Ethnicity wise, 25% of non Hispanic Black males meet the criteria in 
comparison to 37% of non Hispanic White males (Ervin, 2009). In a different study, 
Meigs indicates that about 24% of the US population between ages 20-70 have the 
syndrome, which is more common in older and Mexican American individuals (Meigs, 
2002). A third study estimates that 69 million American meet the criteria set by the 
International Diabetes Federation (Schiltz et al., 2009). 
E. Metabolic Syndrome Prevalence in Qatar 
In a recent study by Musalam et al., the Qatari population was found to have high 
prevalence rates of obesity, diabetes, and further with metabolic syndrome prevalence 
rates of 27.6% (ATP III criteria) and 35.4% (IDF criteria) (Musalam et al., 2008). Bener 
et al. (2009) attribute this to the general economic growth witnessed in that geographic 
area. Bener, Zirie, and Al-Rikabi, (2005) find that this influences levels of urbanizations 
and lifestyle leading to increases in diabetes mellitus to the point where many consider it 
a main public health concern in the country. Additionally, the hot weather environment 
seems to be a factor that limits or restricts physical activity opportunities (Musalam et al., 
2008). Al-Sarraj reports similar results from the neighboring United Arab Emirates 
(UAE), where prevalence rates indicate that 39% and 40% of the population has 
metabolic syndrome, according to ATP and IDF respectively (Al-Sarraj 2010). 
The socio-demographic characteristics breakdown of metabolic syndrome patients 
in Qatar, show age and body mass index (BMI) as significant contributors to the 
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prevalence of the disease in Qatar. It also shows a significant relationship with gender, 
and educational status. In regard to gender, females had higher prevalence rates. 
According to the IDF criteria, 61% of females have metabolic syndrome in comparison to 
38.6% of men, the ATP criteria showed lower rates with 56.3% for females, and 43.3% 
for males (Bener et al., 2009). These results are similar to prevalence studies conducted 
in different geographic regions of the world, like the United Kingdom where females had 
a higher prevalence rate of metabolic syndrome 24.9%, in comparison to 17.4% for men 
(Santos et al., 2008). Or like Slovakia, where females report 23.9% in comparison to 
15.9% males (Mokan et al., 2008). 
F. _Metabolic Syndrome Risk Factors 
The Mayo clinic on their website lists the following items as risk factors for 
metabolic syndrome. The first factor is age, as the risk of developing metabolic syndrome 
increases with age. Reports show that metabolic syndrome affects about 10% of those in 
their twenties in comparison to 40% of those that are in their sixties. The second factor is 
diabetes, as the risk of developing metabolic syndrome increases with family history of 
type 2 diabetes, or gestational diabetes. The third factor is race, as some ethnicities seem 
to have higher risk of developing this syndrome, such as Hispanics or Asians. The fourth 
factor is obesity, as a body mass index (BMI) above 25 increases the risk of developing 
the metabolic syndrome. The fifth factor is other diseases, such as high blood pressure, 
cardiovascular disease, or polycystic ovary syndrome may increase risk of developing 
metabolic syndrome (Mayo Clinic, 2009). Meigs indicates that age, weight, and race are 
common risk factors for metabolic syndrome. Additionally, postmenopausal status, 
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smoking, low household income, high carbohydrate diet, and physical inactivity may also 
increase the risk of developing metabolic syndrome (Meigs, 2004). 
Two researchers have studied these risk factors in metabolic syndrome patients in 
Qatar. Mussalam et al. (2008) found abdominal obesity to be the most common factor 
among Qatari patients, which also seems to be more prevalent among females, as 
abdominal obesity prevalence for Qatari females was estimated at 74% in comparison to 
56% for males. Other contributing risk factors reported in the study were genetics, 
environmental factors leading to physical inactivity, and high illiteracy rate (11.8%). In a 
different study, Bener et al. (2009) found that gender, age, and educational status, are 
significant contributors to metabolic syndrome in this population. This study also showed 
a nine fold increase in age specific prevalence, when comparing the age group 20-30 
(7.9%) with the age group 60 and above (70.3%). 
G. Metabolic Syndrome Clinical Implications 
Metabolic syndrome is a medical condition associated with modern western 
civilizations, with many risk factors that come with the name; along comes higher 
susceptibility to a long list of crucial and serious illnesses. Many sources consider this 
disease a major global public health issue that requires a multi factorial effort to curb the 
increasing prevalence. For example, Meigs indicates that patients with metabolic 
syndrome have double the risk of developing CVD, and have four times the risk of 
developing type 2 diabetes in comparison to individuals not classified under metabolic 
syndrome (Meigs, 2002). 
The Metabolic Syndrome Institute associates metabolic syndrome with an 
increased risk of coronary heart disease, myocardial infarction, and stroke in both 
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genders. Furthermore, the institute indicates that metabolic syndrome patients are three 
times more likely to suffer a cardiovascular event as compared to non-metabolic 
syndrome individuals (Metabolic Syndrome Institute, 2010). These associations are 
similar to ones reported in a study conducted by Isomaa et al. (2001), where 3606 
metabolic syndrome patients were followed for 6.9 years. Individuals with metabolic 
syndrome were found to have three times the risk of coronary heart disease, myocardial 
infarction, and stroke in comparison to those without it. Metabolic syndrome patients also 
had a 1.8 times the risk of cardiovascular morbidity. 
H. Components of Human Energy Balance 
Total human energy expenditure is divided into three major components; these are 
basal metabolic rate, thermic effect of food, and activity thermogenesis (Levine, 2007). 
Basal metabolic rate (BMR), or resting metabolic rate (RMR), is the energy used for core 
body functions and is measured during rest while fasting. This contributes to 60-70% of 
all energy utilized, and usually varies by size, the bigger the person the higher the basal 
metabolic rate. Thermic effect of food accounts for about 10-15% of all energy utilized 
and represents the energy needed for digestion, absorption, and storage. For example, 
proteins have the highest thermic effect of all macronutrients, which is followed by 
carbohydrates and then fats (Wilson, 2004). 
Activity thermogenesis accounts for the rest of the energy utilized throughout the 
day, and divides into two components, exercise activity and non-exercise activity 
thermogenesis (NEAT). The former is the energy used when exercising, and the latter is 
the energy used throughout the day for all non-exercise activities, such as shopping, 
mowing the lawn, or fidgeting. This part plays an important role in overall energy 
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balance, and may vary as much as 2000 kcal/day between individuals, which makes it an 
important tool in weight loss or in preventing weight gain (Levine, 2007). 
I. Non-exercise Activity Thermogenesis (NEAT) 
James Levine (2007) describes it as "NEAT includes all those activities that 
render us vibrant, unique, and independent beings such as dancing, going to work or 
school, shoveling snow, playing the guitar, swimming, or walking in the modern mall" 
(p. 275). Some of the activities that classify under NEAT—listed in ascending order of 
energy expenditure- include standing, gum chewing, fidgeting, stair climbing, and 
walking. 
J. Non-exercise Activity Thermogenesis and Obesity 
It is estimated that 1 billion individuals across the globe are overweight or obese; 
this comes as a result of the increased sedentary lifestyle behaviors (Novak & Levine, 
2007). A study conducted at Mayo clinic in 2006, one of the prominent research institutes 
on the topic, found that the mean energy expenditure while seated was approximately 
70 kcal/h, in comparison to walking and working which was about 190 kcal/h, with the 
mean increase of energy expenditure at approximately 120 kcal/h. The study concluded 
that replacing time sitting at the desk by time walking and working, individuals would 
lose 20-30 kg annually if remaining energy components remained the same (Levine & 
Miller, 2007). 
In another study by Levine, the author indicates that when a person walks at 
1 mile per hour, instead of sitting, the energy expenditure of a 70 kg person is 
approximately 100 kcal/h (Levine, 2007). Levine and Kotz (2005) in a third study 
indicate that obesity is associated with a predisposition to be seated for a longer period of 
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time in compare to more lean individuals (about 160 min/day), and if these individuals 
used this time to stand or ambulate they would spend up to 350 kcal/day. 
K. Non-exercise Activity Thermogenesis Strategies 
Examples of activities classified under NEAT—listed in ascending order of 
energy expenditure- include; standing, gum chewing, and fidgeting (Levine, 2007). A 
comparison of the energy expenditure associated with each item is shown in Figure 2.1. 
For example, when a person stands instead of sitting, energy expenditure is increased by 
10% above rest. When a person chews gum, energy expenditure is increased by 20% 
above rest. When fidgeting, energy expenditure is increased by 50%, and when a person 
walks at one mile per hour energy expenditure is doubled (Increasing the rate to three 
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Figure 2.1 Energy expenditure during different activities in comparison to rest (Levine, 
2007). 
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NEAT can be divided into NEAT associated with leisure activities, and NEAT 
associated with occupation or work (Levine, 2007). To promote individual NEAT 
strategies, Levine recommends the following steps: (a) self monitoring and feedback, 
(b) modify specific seated behaviors so that they can be performed while standing, (c) use 
sedentary behaviors to reinforce physically active choices, (d) identify substitutes of 
sedentary behaviors, (e) stimulus control, both at work and home, and (0 presence of a 
motivated team (Levine et al., 2006). 
Kate Trainor states "the beauty of NEAT is that you can start anytime, 
anywhere." Simple items like using the stairs instead if the elevator may burn 12 calories. 
Or like walking the dog which burns 200 calories per hour or up to the 300 calories if it 
was a one hour jog, may increase ones daily NEAT (Trainor, 2009). Strategies that 
increase NEAT at the office or work environment include (a) replacing the chair with a 
treadmill or exercise ball; (b) keeping exercise equipment handy, like mini sized steppers; 
(c) using a pedometer to measure the amount of steps per day with a goal of 10,000 steps; 
(d) keeping walking or running shoes accessible, near the desk; (e) walking while using 
the phone (Trainor, 2009). 
To help ease NEAT into individuals life, Levine recommends the following steps, 
represented by the acronym STRIPE: (a) Select a NEAT activity that is enjoyable to start 
with, (b) Targeted, goals must be well defined, (c) Reward must be per goal, (d) Identify 
barriers and work on overcoming them, (e) Plan NEAT activity sessions, (0 Evaluate 
adherence (Levine, 2007). 
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L. Non-exercise Activity Thermogenesis Measurement 
Several methods that measure NEAT are currently available. For example, Levine 
and Miller used a vertical work station—instead of the typical horizontal one—to assess 
energy expenditure in one of his many studies on the topic. The new work station, which 
he called "walk and work desk" was designed so that participants can walk on a treadmill 
while conducting normal office work on their personal computer which was placed on 
top of the treadmill. The study reports a mean increase in energy expenditure of 119 
kcal/h when using the walk and work desk compared to sitting (Levine & Miller, 2007). 
In a clinical trial conducted by the United States government in 2006, which was 
sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human 
Development (NICHD), participants wore a timed device that vibrates at pre-set intervals 
and measures the amount of NEAT, the results have not been published yet (Non-
exercise Activity Thennogenesis, 2008). Other options that measure energy expenditure 
include pedometers and accelerometers. Some high tech accelerometers can save data for 
days and allows easy transfer to a computer data base for analysis (Kushner & Bessesen, 
2007). 
M. Conclusions 
The Metabolic Syndrome Institute associates metabolic syndrome with an 
increased risk of coronary heart disease, myocardial infarction, and stroke in both 
genders. Furthermore, the institute indicates that metabolic syndrome patients are three 
times more likely to suffer a cardiovascular event in compare to non metabolic syndrome 
individuals (Metabolic Syndrome Institute, 2010). Many studies cover the morbidity and 
mortality of the metabolic syndrome; a lesser number covers it in relation to the Qatari 
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population. From the little research done, it appears necessary to conduct more 
experimental studies on this topic in this population, as the majority of information comes 
from observational studies and personal reviews. In regard to NEAT, the unknown seems 
to outweigh the known. Much more experimental research needs to be conducted in 
relation to the mechanisms of how NEAT works, how it influences obesity, and how to 
convince people to incorporate NEAT into their lives. The results of this study may be of 
use for future preventive care specialists when counseling patients with metabolic 






The study is a randomized experiment, with a pretest and posttest control group. 
There are 200 metabolic syndrome patients, ages 18 and above from Qatar. NEAT 
enhancing activities were used as a lifestyle intervention over a one year period. 
Following the outline shown in Table 1, subjects were followed up twice after baseline 
measurements were taken. Figure 3.1 shows the overall design of the study according to 
Shadish, Cook, and Campbell (2002) notation. 
Baseline 
	
6 months 	 1 year 
0 	x 	 0 	 x 	0 	Experimental group 
R 	0 	 0 	 0 	Control group 
Figure 3.1 The design using Shadish, Cook, & Campbell notation, where X = treatment, 
0 = observation, R = randomized. 
B. Participants 
A total of 200 subjects with metabolic syndrome were recruited from the 
endocrinology and diabetes department clinics at Hamad Medical Corporation in Doha, 
Qatar. The endocrinologist introduced the study to his patients; the ones who decided to 
participate later met with the nurse for a health assessment, and to sign the consent form. 
Finally, subjects met with the research assistant for educational material and further 
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details. Participants were asked to provide demographic data during the initial health 
assessment visit. A designed questionnaire was used to collect patient information such 
as age, gender, and marital status. Additional information collected includes the reason 
for referral, other co morbidities and medications at the start and end of study, along with 
changes. 
The IDF definition for metabolic syndrome was used to establish diagnosis (IDF, 
2006). The inclusion criteria is: patients over the age of 18, who have elevated waist 
circumference (over or equal to 94 cm for men, over or equal to 80 cm for women), and 
two or more abnormalities out of four, of the following: (a) glucose levels over or equal 
to 5.6 mmol/L, or diagnosed diabetes (b) blood pressure over or equal to 130/85 mmHg, 
or drug treatment for hypertension (c) triglycerides levels over or equal to1.7 mmol/L, or 
drug treatment for high triglycerides) (d) HDL levels less than 1,0 mmol/L for men and 
less than 1.3 mmol/L for women, or drug treatment for low HDL. 
The exclusion criteria excluded subjects (a) diagnosed with major illnesses, 
(b) taking any type of medication that may affect weight, and (c) cannot tolerate study 
procedures (NICHD, 2008). 
C. Procedures 
The research assistant randomized subjects to an intervention (n = 100) and a 
control group (n = 100). The randomization list was produced using random allocation 
software. The control group received general dietary and physical activity guidelines. The 
intervention group additionally received information on how to increase their daily 
NEAT. Subjects were followed for one year, during which the waist circumference and 
lipid profile were assessed at baseline, 6, and 12 months. During each of these visits 
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subjects met with the nurse for a weight assessment and to draw blood samples. Subjects 
then met with the research assistant to report their NEAT activity and get educational 
material. 
A contracted marketing company sent a reminder of participation to subjects in 
the intervention group via text messages at 2, 4, 8, and 10 months. The reminder included 
the title of the study, along with instructions on NEAT enhancing activities. For follow 
up visits at 6 and 12 months, participants received a reminder call of their appointment 
date, one week and one day before their arranged appointments. These calls were carried 
out by the nurse or the research assistant according to availability. The above procedures 
were mentioned in detail in the informed consent and were described to subjects before 
they decided whether or not to join. 
D. Measurements 
A Seca digital medical weighing scale was used to obtain weight information, 
which was measured in kilograms. Waist circumference was assessed using a measure 
tape at the level of the superior iliac crest with the person lightly clothed. The fasting 
glucose and lipid profile were assessed by drawing blood samples, and submitting them 
to the facility lab for a report. This includes information on the blood levels of (a) LDL 
cholesterol, (b) HDL cholesterol, (c) total cholesterol, and (d) triglycerides. These were 
measured in millimole per liter. The blood pressure was measured using an electronic 
sphygmomanometer after the patient was seated for 10 minutes. 
E. Intervention 
Subjects were asked to practice the following, NEAT enhancing activities 
recommended by Levine et al. (2006); standing instead of sitting, gum chewing, 
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fidgeting, using the stairs instead of the elevator, walking instead of using the car. This 
information along with the frequency was reported by the subjects on weekly report 
sheets. These were turned in to the research assistant at the 6 and 12 month visit. A copy 
of the report sheet is shown in Table 3. 
F. Data Analysis 
The analysis was based on the results of a repeated measure ANOVA test with 
two groups, with data collected at baseline, 6 months, and 1 year. Results of both groups 
were compared, then, results of the amount of NEAT were compared among the 
intervention group. The independent variable was being in the intervention or the control 
group. The dependent variables were (a) the change in the number of metabolic syndrome 
components at baseline, 6 months, and 1 year; and (b) the change in the number of 
subjects meeting criteria for metabolic syndrome, and were measured on a continuous 
scale. 
G. Power Analysis 
Based on Cohen's (1992) estimation of a medium effect size (f=25), 
power = 80%, and a = 0.05, 64 subjects were needed in each group for a total of 128. To 
allow for any dropouts, the goal was to recruit 200 subjects, 100 per group, which 
allowed for a good dropout rate. 
H. Limitations 
Randomization controls for some threats to validity such as maturation, history, 
regression, instrumentation and selection. However, the design fails to control for other 
sources of threats to internal validity: (a) It is possible that subjects interacted with each 
other at the hospital due to the small size of the waiting room, which may have lead some 
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from the control group to try the intervention on their own. (b) Self-report was used 
during follow up visits where subjects may tend to over report, or simply forget. 
(c) Under attrition, a high dropout rate was experienced. 
The study also fails to control for sources of threats to construct validity: 
(a) Compensatory equalization, it is possible that subjects from the control group may 
have gotten access to information related to the intervention from the hospital personal 
and decided to try it on their own. (b) Compensatory rivalry, it is possible that subjects 
from the control group tried to show that they can do as well as the other group. 
(c) Resentful demoralization, it is possible that subjects from the control group may have 
become resentful because they didn't receive the intervention, and decided to drop out of 
the trial. Finally, under external validity, because the study was conducted in a certain 
geographic area and the patients were of a certain disease, the results of the study cannot 
be generalized to other geographical areas or patients with other types of diseases. 
I. Research Ethics 
Under autonomy, subjects had the right to decide whether to join the study or not. 
Those with diminished autonomy had the right to be protected from harm. Furthermore, 
subjects were asked to sign a consent form, which is a ten page document that covers the 
following items: (a) A description of the study and its purpose. (b) The information the 
participant was asked to give. (c) A description of what the participant was asked to do 
and for how long. (d) A description of potential risks and benefits. (e) A statement 
indicating that participation is voluntary. (f) Reassurance that all data will be confidential. 
(g) The name and number of a person the participant may call to get further information. 
(h) The name and number of a person the participant may call if he has a complaint. 
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(i) Information regarding compensation provided. (j) A description of alternatives to the 
research. (k) Explanation that a summary of the results will be available if wanted. 
(1) Places for signatures (Cone & Foster, 2006). Subjects were asked to sign the consent 
form during the recruitment visit and before receiving any instructions. 
For the sake of protecting patient confidentiality, these documents were kept in a 
designated folder, placed in a locked filing cabinet, located in the assigned research room, 
where the principal investigator was the only person who had access. Additionally, each 
subject was assigned a tracking number, where the list of names and tracking numbers 
were kept separately from the data and the tracking number. Under justice, subjects had 
equal opportunity in participating and benefiting from the research, this was carried out 
by excluding only those that meet the exclusion criteria, and not for any irrelevant factor 
like age or gender. Participants were recruited fairly using randomization which allowed 
each participant a 50% chance of being in either group. Also, subjects were informed of 
alternative treatments. Under beneficence, harm was minimized and benefits were 
maximized, any risks or advantages were revealed to subjects during the initial visit with 
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Qatar shares the burden of much of the rest of the world with high prevalence of 
metabolic syndrome. In a recent study, gender, age, and educational status were 
significant contributors to metabolic syndrome in this population. Other studies associate 
metabolic syndrome with an increased risk of coronary heart disease, myocardial 
infarction, and stroke in both genders. 
Total human energy expenditure is divided into three major components; resting 
metabolic rate, thermic effect of food, and activity therrnogenesis which is divided into 
exercise and non exercise activity thermogenesis (NEAT). In this study NEAT was used 
as a lifestyle intervention on subjects with metabolic syndrome. 200 eligible patients 
from the Diabetes and Endocrinology Department at Hamad Medical Hospital in Doha, 
Qatar were assigned to an intervention (n=100) or control (n=100) group and followed 
for one year. The intervention group was advised to practice NEAT enhancing activities, 
while the control group was not advised about NEAT. Measurements of waist 
circumference, weight, BMI, blood pressure, glucose and lipid profile were assessed at 
baseline, 6 months, and 1 year. After one year 52 intervention and 55 control subjects 
completed the study. The results revealed no statistically significant differences in 
metabolic syndrome components between the two randomized groups. The amount of 
recommended NEAT activity appears to have been too small to influence study 
outcomes. Future studies in similar populations may need to consider the high dropout 
rate, and use of incentives or other interventions to increase compliance and retention. 
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Introduction 
Metabolic syndrome is a combination of several abnormalities that increase the 
risk of cardiovascular disease (CVD) such as increased waist circumference, lipids, or 
blood pressure. Each abnormality is associated with cardiovascular disease cases (1), such 
as stroke, myocardial infarction, and heart failure (2). Worldwide, approximately 20-25% 
of the population suffers the burden of symptoms related to metabolic syndrome (3). The 
burden is shared among the Qatari population, which suffers from high prevalence rates 
of obesity and type 2 diabetes (I). A recent study indicates that the crude prevalence of 
metabolic syndrome in Qatar is 34% according to the International Diabetes Federation 
(IDF) criteria (2). Risk factors associated with metabolic syndrome in the Qatari 
population include age, ethnicity, obesity, and family history of diabetes (2). 
Total human energy expenditure divides into basal metabolic rate, thermic effect 
of food, and activity therniogenesis. Activity thennogenesis is further divided into 
exercise, and non exercise activity thermogenesis (NEAT); NEAT is defined as the 
energy used throughout the day for all non exercise activities (4). Novak and Levine (5) 
show an inverse relationship between sedentary behaviors and physical activity; which 
leads to increased obesity and decreased health at the population level. Structured 
physical activity may help prevent metabolic syndrome (6). One way to increase physical 
activity both on an individual and population level is through increasing NEAT, such as 
walking instead of driving, or taking the stairs instead of using the elevator. 
Gutierrez recommends physical activity as an adjunctive intervention because of 
its positive impact on abnormal lipids. Exercise improves HDL cholesterol levels through 
altering composition and maturation of the particles, as it increases the size of HDL 
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particles and the maturation of the nascent HDL particle. Additionally it improves total 
cholesterol levels (7). Grundy et al. show that lifestyle changes are crucial in hypertensive 
individuals with metabolic syndrome. They recommend physical activity as a tool to help 
control elevations in blood pressure. Additionally, insulin resistant individuals usually 
have abnormal fat distribution which is characterized by upper body fat. The authors 
show that the high release of fatty acids contributes to the accumulation of lipids in other 
sites than adipose tissue such as liver and muscles which contributes to worsening insulin 
resistance in the muscles. Furthermore, they show that patients with metabolic syndrome 
who are physically active may delay or prevent the development of type 2 diabetes (8). 
A lifestyle intervention study was conducted with 200 Qatari subjects identified 
with metabolic syndrome. This proof of concept study aims to understand whether it is 
feasible to attempt to reduce the burden of metabolic syndrome in Qatari outpatients by 
promoting increased NEAT. 
Methods 
The study is a one year randomized experiment, with a pretest and posttest 
intervention and control group. The study was conducted between March 2010 and 
August 2011. NEAT enhancing activities were used as a lifestyle intervention. Subjects 
were recruited from the endocrinology and diabetes department clinics at Hamad Medical 
Corporation in Doha, Qatar. Subjects were asked to sign a written consent form before 
enrollment. The study was approved by the research ethics committee at Hamad Medical 
Hospital in Doha, Qatar (research protocol number 9181/09). Permission for use of the 
data for the first author's dissertation was given by the Institutional Review Board at 
Loma Linda University. 
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The IDF definition for metabolic syndrome was used to establish diagnosis (9). 
The inclusion criteria included subjects over the age of 18, who have elevated waist 
circumference (over or equal to 94 cm for men, over or equal to 80 cm for women), and 
two or more abnormalities out of four, of the following: (a) elevated triglycerides over or 
equal to 150 mg/dL (1.7 mmol/L), or drug treatment for elevated triglycerides; 
(b) reduced HDL cholesterol less than 40 mg/dL (1.0 mmol/L) for males and less than 50 
mg/dL (1.3 mmol/L) for females, or drug treatment for reduced HDL cholesterol; 
(c) elevated blood pressure over or equal to 130 mm Hg for systolic and/or over or equal 
to 85 mm Hg for diastolic, or diagnosed hypertension; and (d) elevated fasting glucose 
above or equal to 100 mg/dL (5.6 mmol/L), or diagnosed diabetes. The exclusion criteria 
excluded subjects: (a) diagnosed with major illnesses; (b) taking any type of medication 
that may affect weight; (c) cannot tolerate study procedures(10). 
Subjects were divided to an intervention (n = 100) and a control group (n = 100). 
The randomized list was produced using random allocation software. The control group 
received general dietary and physical activity guidelines. The intervention group received 
additional information on how to increase their daily NEAT. This information was given 
by the nurse, on a one to one basis, over a 10 minute period of time. Participants also 
received a one page handout explaining different NEAT options and how it works. 
Subjects were asked to practice the following NEAT enhancing activities recommended 
by Levine et al.(4) standing instead of sitting, gum chewing, fidgeting, using the stairs 
instead of the elevator, walking instead of using the car. This information along with the 
frequency was reported by subjects on weekly report sheets that were turned in at their 6-
and 12-month visit. 
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Subjects were followed for 1 year, during which the waist circumference, blood 
pressure, weight, glucose and lipid profile were assessed at baseline, 6, and 12 months. 
Subjects in the intervention group received reminders, via text messages, to practice 
NEAT at 2, 4, 8, and 10 months. 
Measurements 
A Seca digital medical weighing scale was used to obtain body weight. Waist 
circumference was assessed using a measure tape at the level of the superior iliac crest 
with the person lightly clothed. The fasting glucose and lipid profile were assessed by 
drawing blood samples. This included information on the blood levels of total 
cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and glucose (Roche/Hitachi 
modular p chemistry analyzer using enzymatic in vitro assay) at the facility laboratory. 
LDL cholesterol was calculated unless triglycerides were > 4.5 mmol/L, when it was 
measured directly. The blood pressure was measured using an electronic 
sphygmomanometer after the patient was seated for 10 minutes. 
Statistical Analysis 
Power analysis revealed that based on Cohen's estimation of a medium effect size 
(f--25), power = 80%, and a = 0.05, 64 subjects were needed for each group, for a total of 
128(11). Categorical and continuous data were expressed as frequency (percentage) and 
mean + SD. Descriptive statistics were used to summarize all demographic and clinical 
characteristics of the participants. Baseline participant characteristics in the two 
independent groups were compared using an unpaired t-test for continuous variables and 
a chi-square test for categorical variables. For the primary outcome variable i.e., average 
number of components of metabolic syndrome, data from the baseline, 6 months, and 
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12 months were compared using repeated measure analysis of variance (ANOVA). The 
results were presented with the associated 95% confidence interval. Where an overall 
group difference was found statistically significant, pair-wise comparisons were made 
using the appropriate post-hoc test. All statistical tests were two-sided and the p value 
smaller than 0.05 was considered to be statistically significant. All statistical analyses 
were done using statistical packages SPSS 19.0 (SPSS Inc. Chicago, IL). 
Study Progress 
A total of 200 individuals were recruited between March and August of 2010. 
These were randomized using random allocation software into two groups, an 
intervention and control group. At the 6-month visit, 62 were lost at follow up; 32 of the 
intervention and 29 of the control group. Additionally one person died from the latter 
group. At the 12-month visit, 31 additional subjects were lost at follow up, 16 and 15 of 
the intervention and control group respectively. The following flow chart shows the 
overall study progress. 
[Insert Figure 4.1 here] 
Results 
Among those recruited 120 (60%) were men, and 80 (40%) were women. The 
number of males was higher in both groups, 58 in the intervention and 62 in the control 
groups. All subjects were of the same ethnicity as they were all Qatari nationals. The 
mean height for the intervention group was 162.7cm +8.71 (range: 139-182), and for the 
control group 162.5cm +9.29 (range: 143-185). Patient demographics, metabolic 
syndrome components and anthropometrics are listed in Table 1 below. 
[Insert Table 4.1 here] 
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Information regarding the number of components of metabolic syndrome among 
each group is summarized in table 2 below. 
[Insert Table 4.2 here] 
The results showed no significant difference over time between the groups in 
regard to weight, BMI, waist circumference, glucose, HDL cholesterol, triglycerides, 
diastolic, and systolic blood pressure, and the number of metabolic syndrome 
components as well as total and LDL cholesterol. The detailed results are presented in 
Table 3. 
[Insert Table 4.3 here] 
NEAT Activity 
In regard to the frequency of NEAT practiced, among the 40 participants that did 
report their activity, 24 (60%) were found to have practiced NEAT enhancing activities 
1-2 times a week, 10 (25%) practiced it 3-4 times a week, and 3 (7.5%) did it more than 
4 times a week, while 3 (7.5%) reported no activity. 
Discussion 
The increasing prevalence of metabolic syndrome in Qatar is just one indication 
among many that this population is suffering as a result of major lifestyle changes that 
have occurred in the past four decades. In this study on 200 subjects, there was no 
significant difference between the groups on the measures of metabolic syndrome after a 
1-year intervention study. We are unaware of previous studies using NEAT as an 
intervention in patients with metabolic syndrome. Most of the patients were middle aged 
or older, and already had established type 2 diabetes. Such interventions may be effective 
in younger patients, and work better for prevention rather than cure. 
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Factors that play an important role in the development of metabolic syndrome 
include genetics, sedentary lifestyle, cigarette smoking, progressive weight gain, and a 
Western diet (12- 13). Lifestyle plays a major role in the etiology of metabolic syndrome 
either through low physical activity or excess caloric intake or both. The most common 
risk factor seems to be abdominal obesity which majorly justifies lifestyle modification. 
The American Heart Association states that "in the long run, the greatest benefit for those 
with metabolic syndrome will be derived from effective lifestyle intervention" (14). 
Levine et al. (4) show that NEAT plays an important role in overall energy balance 
because it may vary as much as 2000 kcal/day between individuals. Moreover, they 
indicate that highly active people may expend as much as three times more than inactive 
people. In 2006 a study conducted at the Mayo Clinic found that the mean energy 
expenditure while seated was approximately 70 kcal/h, in contrast to walking and 
working which was about 190 kcal/h, with the mean increase of energy expenditure at 
approximately 120 kcal/h. The study concluded that replacing time sitting at the desk by 
time walking and working, individuals would lose 20-30 kg per year, if other components 
of energy expenditure remained the same 
In another study by Levine, the author indicates that when a person walks at 
1 mile per hour, instead of sitting, the energy expenditure of a 70 kg person is 
approximately 100 kcal/h (16). Levine and Kotz in a third study indicate that obesity is 
associated with a predisposition to be seated for a longer period of time in comparison to 
more lean individuals (about 160 min/day), and if these individuals used this time to 
stand or ambulate they would burn up to 350 kcal/day(17). 
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Despite the previously mentioned studies that highlighted the importance and 
effectiveness of NEAT in increasing energy expenditure, components of metabolic 
syndrome showed no significant difference between the groups in this study. This can be 
due to many reasons. Non compliance is one of the major influencing factors, which can 
be due to social norms, or lack of local convincing evidence on the effectiveness of 
NEAT, or lack of awareness. It appears that not enough NEAT was accomplished per 
week to influence the results. It is possible that NEAT should be carried out and practiced 
on a daily basis to the point where it becomes a personal habit or part of one's lifestyle 
before one might expect to see significant results. 
While the results were disappointing they provide a basis for future studies. To 
increase NEAT, more significant activities that expend more energy than others may be 
emphasized like walking. Furthermore, specific goals to be attained in regard to 
frequency and duration of activity should be promoted. Another suggestion would be to 
use pedometers or other physical activity sensors as an incentive to increase NEAT as 
Gardner and Campagna show that such devices help increase motivation and aid in 
raising awareness to different activity patterns 08). Also, self-report was used as a 
reporting method, where subjects may tend to over report, or simply forget. Only 40% of 
participants in the intervention group filled out the report forms. 
Other factors may include the high dropout rate and missing data. To improve the 
dropout rate, one may consider shortening the time between follow up visits or by 
providing incentives at each visit. Other possible options include increasing the frequency 
and type of reminders, such as using phone follow ups on regular basis. Additionally the 
quality of training of personnel who gave the advice may be improved, as well as the 
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quality of advice given. Additionally, many other factors may have influenced 
participants of this study, such as the limited physical activity outlets considering the 
overall hot weather, which also contributes to the common sedentary lifestyle, which is 
quite prevalent in the area, as well as the occurrence of the month of fasting during the 
final evaluation of some participants. 
Due to the high rate of metabolic syndrome locally, it would be beneficial to 
conduct similar studies as the one here but on a larger scale, to help curb the epidemic of 
metabolic syndrome and its hazardous outcome. Such studies should take into 
consideration the high dropout rate which occurred in this study, and should be 
constructed to minimize such occurrences. 
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32 lost to 
follow up 
29 lost to follow up 
1 died 
6 months: 68 6 months: 70 
16 lost to 15 lost to 
follow up follow up 
V V 
12 months: 52 12 months: 55 









Male 58 (58%) 62 (62%) 0.564 
Female 42 (42%) 38 (38%) 
•Age (years) (n=100) (n=100) 
Mean ± SD 57.1±13.44 55.9±12.32 0.490 
Median (Range) 56.5 (20-84) 57.5 (18-85) 
Marital Status (n=100) (n=100) 
Married 83 (83.0%) 88(88.0%) 0.195 
Single 9(9.0%) 10(10.0%) 
Widowed 7 (7.0%) 1 (1.0%) 
Divorced 1 (1,0%) 1 (1.0%) 
Height (cm) (n=100) (n=100) 
Mean ± SD 162.7±8.71 162.3±9.29 0.772 
Median (Range) 162.0(139-182) 161.0(143-185) 
Weight (kg) (n=100) (n=100) 
Mean ± SD 86.9±18.48 87.0±19.25 0.952 
BMI (kg/m') (n=100) (n=100) 
Mean ± SD 33.0±7.04 33.1±7.66 0.935 
Waist circumference (cm) (n=100) (n=100) 
Mean ± SD 108.2±12.26 108.4±14.13 0.902 
Glucose (mmol/L) (n=94) (n=93)  
Mean ± SD 8.4±3.15 8.5±3.5 0.762 
High-density lipoprotein cholesterol (n=92) (n=94)  
(mmol/L) 1.1±0.28 1.1±0.35 0.595 
Mean ± SD 
Low-density lipoprotein cholesterol (n=92) (n=94) 
(mmol/L) 2.7±0.94 2.7±0.89 0.872 	, 
Mean ± SD 
0.970 
Triglyceride (mmol/L) • (n=92) (n=94) 
Mean ± SD 1.6±0.94 1.6±1.1 
Cholesterol (mmol/L) (n=92) (n=93) 
Mean ± SD 4.6±1.1 4.6±1.0 0.965 
Systolic blood pressure (mmHg) (n=100) (n=99) 
Mean ± SD 145.1±18.51 140.5±20.18 0.096 
Diastolic blood pressure (mmHg) (n=100) (n=99) 
Mean ±. SD 76.8±10.65 76.3±10.77 0.744 
Medications (n=90) (n=88) 
Anti-diabetic 
Yes 65 (72.2%) 64 (72.7%) 0.940 
No 25 (27.8%) 24 (27.3%) 
Lipid-lowering 
Yes 62 (68.9%) 62 (70.5%) 0.820 
• No 28 (31.1%) 26(29.5%) 
Anti-hypertensive 
Yes 69 (76.7%) 66 (75.0%) 0.795 
No 21 (23.3?/o) 22 (25.0%) 
Table 4.1 Patient demographics, metabolic syndrome components, and anthropometrics (Quantitative values expressed as mean ± SD/ 





Intervention Control P value 
circumference (n=100)  (n=100) 0.390 
Yes 95 (95.0%) 92 (92.0%) 
No 5 (5.0%) 8 (8.0%) 
Elevated triglycerides (n=94) (n=98)  0.690 
Yes 63 (67.0%) 63(64.3%) 
No 31(33.0%) 35(35.7%) 
Elevated blood pressure (n=100) (n=99)  0.620 
Yes 91(91.0%) 88(88.9%) 
No 9(9.0%) 11(11.1%) 
Reduced HDL cholesterol (n=94) (n=96) 0.134 
Yes 70 (74.5%) 80 (83.3%) 
No 24 (25.5%) 16(16.7%) 
Elevated glucose (n=97) (n=96) 0.502 
Yes 86 (88.7%) 82 (85.4%) 
No 11(11.3%) 14 (14.6%) 






(Mean + SD) 
6 months 
(Mean + SD) 
12 months 
(Mean ± SD) 
p-value* 
Intervention (n=48) 84.2+18.51 84.6+18.46 84.9+19.16 0.677 
Control (n=49) 86.5+20.19 85.9+20.34 86.3+21.23 
Body mass index (kg/m') 
Intervention (n=47) 32.15+7.62 32.26+7.42 32.38+7.74 0.611 
Control (n=49) 33.21+8.32 32.99+8.37 33.12+8.77 
Waist circumference (cm) 
Intervention (n=40) 104.5+13.21 104.6+11.38 104.6+11.44 0.159 
Control (n=47) 108.5+13.21 108.1+13.24 108.4+13.38 
Glucose (mmol/L) 
Intervention (n=45) 8.78+3.54 8.86+3.83 8.62+3.47 0.501 
Control (n=39) 9.42+3.93 9.29+4.42 9.09+4.33 
High-density lipoprotein cholesterol 
(mmol/L) 
Intervention (n=43) 1.14+0.29 1.10±0.25 1.15+0.28 0.396 
Control (n=38) 1.05+0.31 1.03+0.28 1.15+0.51 
Low-density lipoprotein cholesterol 
(mmol/L) 
Intervention (n=43) 2.57+0.81 2.63+0.71 2.58+0.68 0.789 
Control (n=39) 2.53+0.79 2.56+0.70 2.58+1.05 
Triglyceride (mmol/L) 
Intervention (n=43) 1.64+0.93 1.47+0.68 1.51+0.65 0.124 
Control (n=39) 1.79+1.45 2.02+1.66 1.87+1.35 
Cholesterol (mmol/L) 
Intervention (n=43) 4.55+0.90 4.40+0.73 4.38+0.82 0.889 
Control (n=39) 4.41+1.09 4.45+0.82 4.54+1.42 
Systolic blood pressure (mmHg) 
Intervention (n=43) 144.77+19.60 137.49+18.76 137.21+16.64 0.456 
Control (n=46) 142.07+19.94 143.59+18.82 141.24+19.19 
Diastolic blood pressure (mmHg) 
Intervention (n=43) 75.79+9.03 75.12+9.39 72.72+9.46 0.218 
Control (n=46) 75.70+11.76 78.22+10.81 76.15+10.43 
Number of components of metabolic 
- syndrome 
Intervention (n=50) 3.64+0.77 3.68+0.79 3.78+0.76 0.059 
Control (n=45) 3.98+0.78 3.96+0.85 4102+0.86 
Table 4.3 Comparison of anthropometrie and metabolic parameters at baseline, 6 months, and 12 months in completers in the 





In this proof of concept study, there were no differences in metabolic syndrome 
components between groups randomized to the NEAT or control interventions. In order 
to clarify whether certain subgroups showed changes in parameters following the 
intervention, we compared results in the intervention and control groups among 
individuals with diagnosed diabetes, among males and females separately, and among 
subjects that reported the amount of NEAT performed. Finally we looked at baseline 
characteristics of completers versus non-completers of the study to better understand 
characteristics associated with compliance. 
B. Results in Individuals Using Anti-Diabetic Medications 
Physical activity in general and NEAT in specific benefit diabetic individuals 
through improving their sensitivity to insulin therefore reducing their risk for CVD. Sigal 
(2006) indicates that exercise for two months or more is significantly effective in 
reducing HbAl c in patients with type 2 diabetes. This section had two goals, (a) to look 
at the risk level of those using anti-diabetic medications versus their counterparts not 
taking medications, and (b) to examine if results in those on anti-diabetics differed from 
the whole 'group (because of their higher risk level). 
In this study, 72.2% of the intervention groups were using anti-diabetic 
medication, while 27.8% were not. For the control group 72.7% were using anti-diabetic 
medication, while 27.3% were not. To compare risk factors among those on anti diabetic 
mediations and those not on medications, we ran a chi square test on the 5 components of 
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metabolic syndrome. Not surprisingly, as shown in the table below almost all those on 
anti-diabetic medication fulfilled the high glucose criterion of metabolic syndrome. In 
addition subjects on anti-diabetic medication were more likely to meet the low HDL 
cholesterol criterion of metabolic syndrome than their counterparts. 
Table 5.1 Percentages of Risk Factors Among Those Using and Not Using Anti Diabetic 
Medications (p-value derived using chi square test) 
Components of metabolic 
syndrome 




Elevated triglycerides (n=175) 










Yes 91 (72.0%) 29(59:3%) 0.950 
No 35 (27.8%) 20 (40.8%) 
Elevated blood pressure 
(n=177) 116(90.6%) 45 (91.8%) 0.801 
Yes 12(9.4%) 4 (8.2%) 
No 
Reduced HDL cholesterol 
(n=173) 108 (85.0%) 33 (71.7%) 0.047 




Yes 128(99.2%) 29 (63%) 0.000 
No 1 (8.0%) 17(37%) 
C. Comparison Between Groups 
When looking at those participants that were treated with anti diabetic 
medications alone in the NEAT intervention versus the control group, upon analyzing the 
results using, a repeated measures ANOVA test; there was no significant difference over 
time between the groups in regard to weight, BMI, waist circumference, glucose, HDL 
cholesterol, triglycerides, diastolic and systolic blood pressure, as well as total and LDL 
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cholesterol and the number of metabolic syndrome components. The table below 
summarizes the results. 
Table 5.2 Comparison of Anthropometric and Metabolic Parameters at Baseline, 6 
Months, and 12 Months in Completers in the Intervention and Control Group Among 
Those on- Anti-diabetic.Medication (p-value derived using repeated measure ANOVA 
test) 
Variable Baseline 
(Mean ± SD) 
Time Points 
6 months 
(Mean ± SD) 
12 months 
(Mean ± SD) 
p-value* 
Weight (kg) 	Intervention(n=37) 82.0±15.79 82.4±15.65 82.5±15.98 0.888 
Control(n=33) 82.3±16.38 81.5±16.81 81.5±16.98 
Body mass index (kg/m2) 
Intervention(n37) 31.0±6.34 31.2±6.09 31.2±6.27 0.933 
Control(n33) 33.2±6.03 30.9±6.31 30.9±6.46 
Waist circumference (cm) 0.291 
Intervention(n32) 103.3±11.86 103.4±11.81 103.4±11.92 
Control(n=31) 106.9±12.90 106.6±12.87 106.7±12.98 
Glucose (mmol/L) 0.489 
Intervention(n35) 9.64±3.52 9.59±3.84 9.44±3.42 
Control(n=31) 10.37±3.85 10.23±4.46 9.79±4.58 
High-density lipoprotein cholesterol 
(mmol/L) 	 Intervention (n=35) 1.12±0.26 1.09±0.22 1.14±0.27 0.709 
Control(n=30) 1.05±0.33 1.03+0.28 1.19±0.56 
Low-density lipoprotein cholesterol 
(mmol/L) 	 Intervention (n=35) 2.54±0.87 2.61±0.73 2.49±0.67 0.627 
Control(n=30) 2.37±0.76 2.48±0.71 2.55±1.15 
Triglyceride (mmol/L) 
Intervention (n=35) 1.69±1.00 1.48±0.67 1.49±0.65 0.166 
Control(n=30) 1 85±1 64 2.05±1.84 1.93±1.51 
Cholesterol (mmol/L) 
Intervention (n=35) 4 53±0.96 4.36±0.75 4.26±0.81 0.835 
Control(n=31) 4 31±1.15 4.39±0.86 4.59±I.55 
Systolic blood pressure (mmHg) 
Intervention (n=36) 146.00±20.83 138.83±19.61 138.89±17.23 0.978 
Control(n=32) 141.50±21.84 142.88±20.51 139.69±19.91 
Diastolic blood pressure (mmHg) 
Intervention (n=36) 75.25±9.19 75.42±9.88 72.64±9.69 0.603 
Control(n=32) 75.44±10.14 76.69±10.86 74.25±10.05 
Number of components of NIS 
Intervention (n=39) 3.69±0.83 3.79±0.80 3.82±0.75 0.143 
Control(n=36) 4.00±0.75 4.00±0.86 4.06±0.86 
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D. Results by Gender 
The results of comparing the groups over time, for males only, showed no 
difference for all variables except for the number of metabolic syndrome components 
which shows a significant increase in the intervention group while there is a tendency 
toward lowering of triglycerides in males in the intervention group. None of the risk 
factors were numerically worsened in the males in the intervention group, but as the 
definition of metabolic syndrome is based on medications used, not only on blood test 
values, that may be the explanation of this result. The results of an analysis using a 
repeated measure ANOVA test, on males alone, is listed in Table 5.3. 
Table 5.3 Comparison of Anthropometric and Metabolic Parameters at Baseline, 
6 Months, and 12 Months in Completers in the Intervention and Control Group Among 





(Mean ± SD) 
12 months 
(Mean ± SD) 
p-value 
Weight (kg) 	Intervention (n=26) 83.04+14.69 83.90+14.78 83.92+15.23 0.746 
Control (n=29) 85.31+18.30 84.78+18.89 85.28+19.31 
Body mass index (kg/m2) 
Intervention (n=25) 28.98+4.72 29.32+4.79 29.31+4.98 0.467 
Control (n=29) 30.29+5.19 30.09+5.47 30.33+5.80 
Waist circumference (cm) 
Intervention (n=24) 104.17+9.70 104.42+9.82 104.37+9.87 0.645 
Control (n=27) 105.85+12.51 105.69+12.62 105.85+12.66 
Glucose (mmol/L) 
Intervention (n=24) 9.69+4.12 8.8+3.94 9.14+3.87 0.892 
Control (n=26) 9.05+3.51 9.4+4.84 9.62+4.88 
High-density lipoprotein 
cholesterol (mmol/L) 
Intervention (11=25) 1.08+0.25 1.05+0.24 1.09+0.24 0.599 
Control (n=27) 0.99+0.30 0.99+0.28 1.12+0.58 
Low-density lipoprotein 
cholesterol (mmol/L) 
Intervention (n=25) 2.71+0.87 2.78+0.81 2.74+0.68 0.298 
Control (n=27) 2.56+0.85 2.54+0.68 2.53+1.10 
Triglyceride (mmol/L) 
Intervention (n=25) I 56+1 04 1.35+0.71 1.43+0.58 0.060 
Control (n=27) I 96+1 71 2.28+1.93 2.02+1.58 
Cholesterol (mmol/L) 
Intervention (n=25) 4.63+0.97 4.46+0.81 4.49+0.89 0977 






Baseline 	6 months 	12 months 	p-value 
(Mean ± SD) (Mean ± SD) (Mean ± SD) 
Systolic blood pressure 
(mmHg) 	Intervention (n=23) 142.78+18 136.61+19.22 140.26+18.23 0.666 
Control (n=27) 142+19.75 142.44+19.79 141.11+19.20 
Diastolic blood pressure 
(mmHg) 	Intervention (n=23) 75.74+9.21 76.57+9.57 75.52+10.19 0.491 
Control (n=27) 76.44+10.60 79.22+11.34 76.96+9.52 
Number of components of MS 
Intervention (n=30) 3.57+0.77 3.63+0.76 3.80+0.76 0.007 
Control (n=28) 4.14+0.75 4.18+0.77 4.18+0.72 
As for females, the results of comparing the groups over time, show no difference 
for all variables between the intervention and control groups. The results of an analysis 
using a repeated measure ANOVA test, on females alone, is listed in Table 5.4 below. 
Table 5.4 Comparison of Anthropometric and Metabolic Parameters at Baseline, 
6 Months, and 12 Months in Completers in the Intervention and Control Among Males 
(p-value derived using repeated measure ANOVA test) 
Variable Baseline 
(Mean ± SD) 
Time Points 
6 months 
(Mean ± SD) 
12 months 
(Mean ± SD) 
p-value 
Weight (kg) 	Intervention(n22) 85.73+22.50 85.44+22.38 86.5+23.29 0.762 
Control(n=20) . 88.25+23.04 87.65+22.68 87.8+24.18 
Body mass index (kg/m2) 
Intervention(n=22) 35.76+8.72 35.61+8.51 35.88+8.87 0.608 
Control(n=20) 37.44+10.18 37.20+10.07 37.17+10.75 
Waist circumference (cm) 
Intervention(n=16) 105.06+13.91 104.94+13.74 104.94+13.81 0.143 
Control(n=20) 112.20+13.56 111.57+13.62 111.90+13.85 
Glucose (mmol/L) 
Intervention(n=21) 7.74+2.41 8.94+3.8 8.04+2.95 0.402 
Control(n=13) 10.16+4.74 9.07+3.6 8.01+2.83 
High-density lipoprotein 
cholesterol (mmol/L) 
Intervention (n=18) 1.23+0.34 1.17+0.25 1.24+0.32 0 819 
Control(n=11) 1.21+0.29 1.13+0.24 1.23+0.30 
Low-density lipoprotein 
cholesterol (mmol/L) 
Intervention (n=18) 2.39+0 77 2.43+0.47 2.35+0.53 0.388 




(Mean ± SD) 
6 months 
(Mean ± SD) 
12 months 






















Systolic blood pressure 
(mmHg) 	Intervention (n=20) 147.05+21.52 138.50+18.67 133.70+14.26 0.526 
Control (n=19) 142.16+20:75 145.21+17.75 141.48+19.71 
Diastolic blood pressure 
(mmHg) 	Intervention (n=20) 75.85+9.06 73.45+9.13 69.5+7.55 0.337 
Control (n=19) 74.63+13.47 76.79+10.13 75.0+11.78 
Number of components of 
MS 	 Intervention (n=20) 3.75+0.78 3.75+0.85 3.75+0.78 0.803 
Control (n=17) 3.71+0.77 3.59+0.87 3.76+1.03 
E. Subjects Reporting NEAT Versus Not Reporting NEAT in the 
Intervention Group 
As for those that did report their NEAT activity; we ran a separate analysis 
comparing these participants alone, on the different variables used previously using a 
paired t test comparing baseline and 6 months, and baseline and 12 months, to examine 
whether or not their NEAT activity modified their metabolic syndrome components. The 
results showed no difference for all variables between baseline and 6 months and baseline 
and 12 months. The results are shown in Table 5.5. 
Table 5.5 Comparison of Anthropometric and Metabolic Parameters Among Those That 
Did Report Their NEAT (p-value derived using a paired t-test) 
Variable Mean p-value 
Weight (kg) 
baseline vs. 6 months (n=29) 89.90 90.28 .312 
baseline vs. 12 months (n=22) 86.41 87.18 .209 
Body mass index (kg/m') 
baseline vs. 6 months (n=29) 33.42 33.56 .306 
baseline vs. 12 months (n=22) 32.66 32.93 .286 
Waist circumference (cm) 
baseline vs. 6 months (n=28) 108.93 109.00 .663 




baseline vs. 6 months (n=30) 9.07 8.36 .148 
baseline vs. 12 months (n=23) 9.09 9.03 .918 
High density lipoprotein cholesterol (mmol/L) 
baseline vs. 6 months (n=29) 1.140 1.06 .333 
baseline vs. 12 months (n=20) 1.250 1.20 .278 
Low density lipoprotein cholesterol (mmol/L) 
baseline vs. 6 months (n=29) 2.68 2.56 .399 
baseline vs. 12 months (n=20) 2.73 2.54 .267 
Triglycerides (mmol/L) 
baseline vs. 6 months (n=29) 1.84 1.61 .158 
baseline vs. 12 months (n=20) 1.66 1.50 .474 
Cholesterol (mmol/L) 
baseline vs. 6 months (n=29) 







Systolic blood pressure (mmHg) 
baseline vs. 6 months (n=28) 148.75 140.93 .062 
baseline vs. 12 months (n=22) 146.00 139.09 .142 
Diastolic blood pressure (mmHg) 
baseline vs. 6 months (n=28) 78.43 76.18 .275 
baseline vs. 12 months (n=22) 76.86 75.45 .595 
Number of components on metabolic syndrome 
baseline vs. 6 months (n=32) 3.63 3.75 .255 
baseline vs.12 months (n=22) 3.55 3.59 .576 
F. Characteristics of Completers Versus Non-completers 
Since the characteristics of completers might be different than non-completers, we 
ran a separate analysis using an independent t test to explore baseline metabolic 
parameters and other anthropometric measurements between the two groups. The 
analysis revealed that mean LDL cholesterol and total cholesterol levels were statistically 
significantly different between groups. It was observed that that mean LDL cholesterol 
and total cholesterol levels were significantly higher among non-completers than 
completers. Additionally, the results indicate that more men than women were non-
completers (66% of non-completers versus 54.2% of completers). These results may 
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become useful to future researchers when deciding on their study populations. The results 
are summarized in Table 5.6. 
Table 5.6 Comparison of Anthropometric and Metabolic Parameters Among Completers 
and Non-completers (p-value derived using independent t-test) 
Variable Completers Non-completers p-value 
Gender (n=107) (n=93) 0.073 
Male 58 (54.2%) 62 (66.7%) 
Female 49(45.8%) 31(33.3%) 
Height (cm) (n=107) (n=93) 0.349 
Mean 1 SD 162.0+9.19 163.2+8.74 
Weight (kg) (n=107) (n=93) 0.263 
Mean ± SD 85.6+18.70 88.5+18.93 
BMI (kg/m2) (n=107) (n=93) 0.649 
Mean ± SD 32.8+7.74 33.3+6.89 
Waist circumference (cm) (n=107) (n=93) 0.219 
Mean ± SD 107.2+11.89 109.5+14.53 
Glucose (mmol/L) (n=106) (n=81) 0.541 
Mean ± SD 8.6+3.56 8.3+3.08 
High-density lipoprotein cholesterol (n=105) (n=81) 0.971 
(mmol/L) 1.1+0.31 1.1+0.33 
Mean ± SD 
Low-density lipoprotein cholesterol (n=105) (n=81) 0.002 
(mmol/L) 2.5+0.83 2.9+0.96 
Mean ± SD 
Triglyceride (mmol/L) (n=105) (n=8I) 0.576 
Mean ± SD 1.6+1.19 1.6+0.83 
Cholesterol (mmol/L) (n=105) (n=80) 0.008 
Mean ± SD 4.4+0.99 4.8+1.10 
Systolic blood pressure (mmHg) (n=107) (n=92) 0.496 
Mean ± SD 141.9+19.32 143.8+19.66 
Diastolic blood pressure (mmHg) (n=107) (n=92) 0.070 
Mean ± SD 75.31+10.45 78.0+10.83 
Components of metabolic syndrome (n=105) (n=89) 0.796 
Mean ± SD 3.72+0.83 3.75+0.69 
Medications (n=102) (n=76) 
Anti-diabetic 
Yes 76 (74.5%) 53 (69.7%) 0.481 
No 26 (25.5%) 23(30.3%) 
Lipid-lowering 
Yes 68 (66.7%) - 56 (73.7%) 0.314 
No 34 (33.3%) 20 (26.3%) 
Anti-hypertensive 
Yes 77 (75.5%) 58 (76.3%) 0.899 
No 25 (24.5%) 18(23.7%) 
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G. Conclusion 
This study looked into whether or not giving advice to increase daily NEAT 
would influence metabolic markers in participants. The theoretical framework suggested 
that since NEAT is part of human energy expenditure, then increasing NEAT throughout 
the day would increase energy expenditure among metabolic syndrome patients, thus 
improving their metabolic markers, and in turn positively adjusting their risk of CVD. 
Giving advice to increase daily NEAT showed no significant effects on metabolic 
syndrome components in this study. These additional analyses looking at subgroups of 
study individuals also found no significant differences between groups according to use 
of anti-diabetic medication or gender (with the exception that the number of metabolic 
syndrome components seemed to increase in men in the intervention group). In addition, 
subjects that reported NEAT did not differ in their results from subjects that did not 
report NEAT. Finally, non-completers tended to be males, and had higher total and LDL 
cholesterol levels than completers. Future researchers might build on this study by 
conducting studies in a shorter period of time, using more efficient follow up methods; 
like increasing the frequency of follow up visits, or by providing incentives to 
• participants at each visit. Additionally, the main concept of the study may be studied 




The results of the study show no significant difference in metabolic syndrome 
parameters between the group that received advice to practice NEAT and the control 
group. These results also apply to comparisons made between those on anti diabetic 
medications and those that are not on anti diabetic medications. Additionally, they also 
apply for comparisons made between genders. 
The concept of the study originated during one of Dr. Tonstad's classes which 
was titled "Obesity and Disordered Eating," during which the concept of NEAT was 
covered as a method of increasing energy expenditure among obese individuals. I further 
researched the topic to find it used in several of Levine's studies. After deciding on doing 
this study in Qatar, I looked into what disease should be chosen and realized that the 
country had high numbers of obesity and diabetes. Therefore I decided to go with 
metabolic syndrome as it includes both an overweight and increased glucose aspect. 
Conducting this study in all its steps and stages was a good learning experience, 
as I had the chance to be exposed to the different aspects of a study, starting from the 
process of planning the different steps of it, obtaining IRB approval, collecting the data, 
analyzing, and interpreting it. All these were the principles that I learned theoretically in 
the classroom through classes taken during the course of my studies. But doing it in 
person brought things into perspective, and a lot of information learned took place in 
reality. 
One of the more pleasurable parts of the study was interaction with patients which 
was a rich learning experience. Reflecting on some of the conversations I had with some 
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of the participants, I learned that people in Qatar have certain restrictions prohibiting 
them from exercising in what can be considered as conclusive reasons that exist in such a 
culture. During one conversation with one of the participants, she indicated that the major 
factor behind her failure to exercise was the presence of non-family members in their 
house yard, such as the driver or other house help that commonly work in homes of 
Qataris, in many cases not out of necessity but rather as a cultural norm. 
On the other hand, another participant expressed that she was pleased with this 
method of increasing energy expenditure, referring to NEAT, and said she finds it to be 
an easy and accessible method to do so. She now used the stairs whenever visiting her 
doctor, occasionally asks her driver to park further down the parking lot, when weather 
permits so. Additionally she tries to walk around the house for a few minutes each day, 
and takes the longer route to things that are within house limits, like when going to the 
kitchen or trying to reach the living room. 
On a different aspect I find several areas of the study that are worth improving or 
changing. First example is the setting of the study, had it allowed us to include younger 
participants, rather than older participants with established disease - about three-fourths 
of the subjects were treated with anti-diabetic medication. Furthermore, all of the 
participants were of the same ethnicity, limiting generalizability. 
Another item is related to health education and raising awareness to the negative 
aspect of metabolic syndrome and the positive aspects of the concept of NEAT. Had the 
participants been scheduled for monthly visits with a health educator to highlight the 
previously mentioned points, it would have possibly helped some participants in realizing 
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the risks associated with the disease along with the benefits of NEAT and increased their 
motivation for change. 
In all, the concept of NEAT as shown in literature through Levine's studies was a 
feasible approach to recruitment of subjects. 200 subjects were recruited and followed up 
within a short period of time. Thanks to my advisors and staff at the hospital for 
facilitating this study. Though the results were disappointing, future efforts should 
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(from Form Page 4) 
2nd ADDITIONAL 
YEAR OF SUPPORT 
REQUESTED 
3rd ADDITIONAL 
YEAR OF SUPPORT 
REQUESTED 
4th YEAR 5th YEAR 
PERSONNEL: Salary and fringe 
benefits. Applicant organization 
only. 1500 















SUBTOTAL DIRECT COSTS 




TOTAL DIRECT COSTS 2500 




The budget has five major categories; these are personnel, consultant costs, 
equipment, supplies, and communication expenses. Under personnel, a nurse charges 
$500, a total of three nurses will participate for a total of $1500. Under consultant costs, a 
research assistant charges $800 per study. Under equipment, the educational material to 
be given to participants will be purchased in bulk from the health education department at 
Hamad General Hospital. The cost for a total of 200 booklets is $50. Under supplies, 
office supplies and paper copies cost approximately $50. Under other expenses, the 
contracted marketing company charges 25 cents for each text message including a 
reminder message of participation. A total of 400 reminders will be sent over a one year 
period for the cost of $100. This brings the grand total to $2500. 
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APPENDIX C: REPORT SHEET USED IN CURRENT STUDY 





























APPENDIX D: CONSENT FORM IN ENGLISH 








HGH • • RH • AAH • AKH • 
Others s 
GENERIC SIGNED CONSENT FORM 
You are invited to participate in this study entitled "The effect of non-exercise  
activity thermo genesis (NEAT) on weight among Qatari patients  
with metabolic syndrome, a randomized controlled study". You are 
free to ask as many questions as you like before, during or after in this research, 
you decide to give consent to participate in this research study. The information 
in this form is only meant to better inform you of all possible risks or benefits. 
Your participation in this study is voluntary. You do not have to take part in this 
study, and your refusal to participate will involve no penalty or loss of rights to 
which you are entitled. You may withdraw from this study at any time without 
penalty or loss of rights or other benefits to which you are entitled. The 
investigator(s) may stop your participation in this study without your consent for 
reasons such as: it will be in your best interest; you do not follow the study plan; 
or you experience a study-related injury. Randomization will be carried out by 
asking patients to randomly choose from two envelopes that contain the type of 
group. 
Project title: The effect Non Exercise Activity Thermogenesis (NEAT) on weight 
among Qatari subjects with metabolic syndrome; a randomized controlled study. 
Name of Principal Investigator: 
Dr. Samer Hammoudeh 
Location and phone numbers: 




Dr. Mahmoud Zirie 
Dr. Abdullah Al-Hamaq 
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Introduction to the research 
Metabolic syndrome is a combination of medical conditions in one person that 
increase the risk of that person to develop diabetes as well as diseases of the heart 
and blood vessels. Metabolic syndrome is very common that it affects one in five 
people, and the chance of getting it increases with age. Persons who suffer from 
the metabolic syndrome are usually overweight, stressed, have high blood 
pressure, and high fat levels in their blood. In addition, their body cannot use its 
insulin, the hormone that is supposed to regulate blood sugar, in a proper way. 
Many treatments have been proposed to prevent the development of metabolic 
syndrome. These include increased physical activity (such as walking 30 minutes 
every day), and eating healthy food that is low in fat. There are many researches 
that support the value of a healthy lifestyle as above. But keeping up with such 
life style is difficult for many people, that is why we decided to do research in one 
of the life style modifications that does not require physical activity. This is called 
non exercise activity thermogenesis (NEAT). We will use this lifestyle 
intervention on high risk Qatari individuals with components of metabolic 
syndrome. 
i-Purpose of the research: 
The purpose of this study is to examine the effect of non exercise activity 
thermogenesis (NEAT) in reducing the following metabolic syndrome markers; 1-
weight 2- waist circumference 3- hip circumference 4- triglycerides level. These 
markers will also be used to establish high risk criteria. 
2-Selection of research subjects: 
You will be invited to participate in this research if you are over i8 years old and 
you have A and 2 out of 5 of the following criteria: 
A) Elevated waist circumference of 102 cm or above (men) and 88 cm or above 
(women) 
B) Fasting blood sugar over 5.6 mmol/L 
C) Blood pressure over or equal 130/85 mmHg 
D) Triglycerides above or equal 1.7 mmol/L 
E) HDL cholesterol lower than 1.o3mmol/L (men) and 1.29 mmol/L ( women) 
3-Distinction between routine care and research activities: 
Your participation in this research is completely voluntary; you will continue your 
treatment with your doctor as usual. Should you choose to participate in this 
research; you will be advised on ways to modify your diet and life style. For 
example, you will be advised to do some activities that you were not doing before 
like parking your car away instead of close to the entrance, standing instead of 
sitting for long time, moving your legs and arms as much as you can during the 
day and other such non-exercise activities. You may or may not benefit from this 
life style modification, but previous research have shown benefit from these 
changes. 
4-Explanation of the procedures: 
The tool "NEAT" that we will use in this research is defined as all other 
movements outside of exercise such as walking, talking, toe tapping, guitar 
playing, dancing or shopping. Researchers found that obese move 2.5 hours less 
per day than lean people. This equates to 350 calories expended per day. What all 
this means is that society as a whole needs to be moving move and spend less 
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time sitting around at the office, watching TV etc. If you watch TV you only burn 
5 calories an hour above your metabolic rate. After 4 hours of sitting and 
watching TV you have only burned 20 calories. 
5-The risks and discomfort involved: 
You will spend more time in doing more of the Non Exercise Activities than 
sitting. There is no risk for you and no discomfort. You may feel better. 
6-The Safety precautions in this research: 
There are no safety precautions 
7-The benefits of the study: 
You may or may not benefit from this research. If you benefited from this 
research, you may be able to lose weight, which may result in better control of 
blood sugar, high blood pressure, and blood fat levels. 
8-The alternative procedures or treatments for this research: 
If you decide not to participate in this research, you can continue the same 
treatment that you are already on. 
9-The options to remain on the research treatment after termination 
of the research: 
Your participation in this research is expected to last for one year. After one year, 
we encourage that you continue these activities on your own. 
10-Details of the person to contact in case of Injury or enquiry during 
the research: 
Dr. Samer Hammoudeh 7007642 -5546316 
ii-Details of the financial or other compensatior which might be 
provided to the research participants if any: 
We will not provide money for your participation in this research. 
12-Duration of the research: 
If you participate in this research, you will be asked to come for a hospital visit at 
6 and at 12 months after your enrollment. You will receive by mail reminders to 
these NEAT exercises and visits. 
13-Where the research is going to be conducted: 
The research will be conducted at your home. You will be assessed in the 
outpatient clinic on the day of your appointment. 
14-Assurance of anonymity and confidentiality: 
Total privacy cannot be guaranteed. We will protect your privacy to the extent 
permitted by law. All research data will be stored in a password protected 
computer. If the results from this research are published, your name will not be 
made public. The following may look at your research and medical records: The 
research team or persons authorized by the research team; the research 
committee member's if/when they choose to. 
15-Non-coercive disclaimer: 
There is no pressure on you to participate in the study; you are free to choose any 
of the treatment modalities offered and that there will be no pressure on you to 
continue in the study even after enrollment. You are free to withdraw from this 
research at any time, and this decision will not and in any way affect the medical 
care you are entitled to. 
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16-Option to withdraw from the study without penalty: 
You can withdraw at any time from the study even after enrollment in the 
research without any penalty. 
17-Details about termination of the study: 
The study will continue for one year for the participant. At the end of the study 
you may continue these activities as part of your learned life style modification 
activities. • I. 
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APPENDIX F: APPROVAL LETTER FROM HAMAD 
HOSPITAL 
HAMAD MEDICAL CORPORATION 
Ref. No: RC/1092/2010 
Date: 31" January20 I 0 
Prof. Abdulbari Bener 
Consultant & Head 
a.\ 1 h II � a . ., . .,� 
Medical R�scarch Centre 
& Research Committee 
Tel: 4392440/Fax: 4395402 
Department of Epidemiology & Medical Statistics 
Dear Prof. Bcner 
Research Protocol #9181/09:-The effect of "Non exercise activity 
thermogeneis (NEAT) "on weight loss among Qatari subjects with 
metabolic syndrome in a randomized clinical trial. 
Reference is made to the above Research Protocol submitted for review and 
approval from the Research Committee. 
On behalf of the Research Committee, it is to inform you that the above 
Research Proposal meets up with the ethical requirements of the Hamad 
Medical Corporation and approval is granted for one year from 3 I st January 
2010. 
Signed Infonned Consent should be taken from each participant. One copy 
of the consent should be handed over to the participant and the second copy 
should be kept with Principal Investigator whereas the third copy of the 
same should be kept in su�ject's Medical Record. 
Progress report of the study should be submitted bi-annually and final rep011 
upon completion to Medical Research Centre. 
We wish vou all success and await the result in due course. 
Yomssi \�
Dr. Rajvir gh 
Coordinator, Research Committee 
Cc: 
1) Dr. Samcr Hammoudeh, DDS, MPH, Dr. PH Student, Loma Linda
University, USA
2) Dr. Mahmoud Zirie, Head of the Department of Endocrinology
3) Dr. Abdullah Al-Hamaq, President of Diabetes Association, Qatar
Foundation
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INSTITUTIONAL REVIEW BOARD 
SPONSORED RESEARCH • 11 t 88 Anderson Street • Loma Unda, CA 92350 
(909) 558-4531 {voice)• (909) 558-0131 {fax) 
Initial Approval Notice - Expedited 
To: Tonstad, Serena 
Department: Health Promotion & Education 
Protocol: The effect of non-exercise activity thermogenesis on subjects with metabolic syndrome 
/RB# 5110341 
This study was reviewed and approved administratively on behalf of the IRB. This decision includes the following determinations: 
Risk to research subjects: Minimal 
Approval period begins: 01-Mar-2012 and ends 28-Feb-2013 
Stipulations of approval: Research intervention is unde IRB approved by Hamad Medical Corp. 
Consent Form 
Unless IRB has given a specific waiver of informed consent (as documented in the approval stipulations above) the IRS-approved and 
stamped consent form accompanies this letter. This now becomes the official master consent form for making copies to provide to 
study participants. 
Adverse Events I Protocol Changes 
The IRB should be notified in writing of any modifications to the approved research protocol. Adverse effects must be reported to the 
I RB in accordance with institutional policy. If sponsor or contractual adverse event reporting requirements differ from requirements for 
reporting to IRB, all reporting requirements must still be met. 
Protocol Review 
Your protocol is tentatively scheduled for review and renewal at least two weeks prior to the approval end-date indicated above. To 
assure uninterrupted approval of this project, you will be sent a report form to request renewal by completing and timely returning to 
Office of Sponsored Research. Anticipate the approval expiration so your study does not lapse; contact /RB for assistance if 
necessary. In addition to reporting the requested renewal status information, you may also use the form to close the study at that time, 
if applicable. 
Records 
All records re lating to this project, including signed consent forms, must be kept on file for three years following completion of the 
s�1 
Please note the Pl's name and the IRB number assigned to this IRB protocol (as indicated above) on any future communications 
with the IRB. Direct all communications to the IRB c/o the Office of Sponsored Research. 
Thank you for your cooperation in LLU's shared responsibility for the ethical use of human subjects in research. 
Loma Linda University Adventist Health Sciences Center holds Fedcralwide Assurance (FWA) No. 6447 with the U.S. Office for Human Research Protections. and the !RB 
registration no. is t0RG226. This Assurance applies to the following institutions: Loma Linda University, Loma Linda University Medical Center (including Loma Linda 
Unr,ersity Children's Hospital, LLU Community Medical Center), Loma Linda University Behavioral Medicine. and affiliated medical practices groups. 
IRS Chair: /RB Administrator: /RB Specialist: 
Rhodes L. Rigsby, /A.O. Linda G. Halsread. M.A., Director Marl( Testerman 
Deparjment of Medicine Sponsored Research Sponsored Research 
(909) 558-2341, rrigsby@llu.edu Ext 43570, Fax 80131, lhals/ead@//u.cdv Ext 43042, Fax 80131, mlesterman@llu.edu 
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